Podcasts about American Heart Association

Send us a textMost people think memory loss is a downhill slide you can't stop. We don't. In this conversation with neurologist and neuroscientist Dr. Majid Fotuhi, we map out a twelve‑week blueprint that measurably improves memory, focus, and even grows hippocampal volume by targeting the real drivers of decline: poor sleep, chronic stress, insulin resistance, hearing loss, inactivity, and hidden medical issues.Dr. Majid Fotuhi is a pioneering neurologist, neuroscientist, and professor with more than thirty-five years of experience in brain health, memory, neuroplasticity, and the prevention of Alzheimer's disease. His work bridges research, clinical innovation, and public education.He earned his PhD in neuroscience from Johns Hopkins University, completed medical training at Harvard Medical School, and returned to Johns Hopkins for his neurology residency. He currently serves as an adjunct professor at Johns Hopkins University.An author and communicator, Dr. Fotuhi has written several books and is known for making complex science accessible. His excellence in teaching earned him the American Academy of Neurology's prestigious award. His research has appeared in peer-reviewed journals, been presented at major conferences, and cited widely by scientists worldwide.Dr. Fotuhi has created a twelve-week program that has helped thousands of patients with memory loss, brain fog, concussion, mild cognitive impairment, and early Alzheimer's disease. His expertise has been featured by CNN, NBC News, the Today Show, ABC News, The New York Times, The Washington Post, and The Times (London).We start by clarifying what mild cognitive impairment is, how it differs from dementia, and why so many cases are preventable. Dr. Fotuhi explains the “type 3 diabetes” model—how decades of sugar spikes and inflammation erode the blood‑brain barrier and starve neurons of a stable environment. Then we get practical. You'll hear how a personalized “brain portfolio” guides treatment: VO2 max testing to shape exercise, sleep studies and CPAP when needed, targeted brain training that matches deficits, and labs for vitamin D, B12, and omega‑3 status. The results? Early wins in two to three weeks, statistically significant gains at six and twelve, and habits that stick.We don't stop at diet and steps. Oral health impacts cognition by limiting whole foods and increasing inflammation; chewing itself engages neural circuits. Hearing loss quietly accelerates decline—hearing aids can move people from mild impairment back to normal. Add a simple, sustainable food approach—ditch ultra‑processed foods, eat vegetables, legumes, fruits, quality proteins, and healthy fats—and consider targeted supplementation with DHA/EPA omega‑3s and corrected D and B12 levels. Along the way, we address why amyloid hogged the spotlight, and point to powerful data: the Lancet's estimate that 45% of dementia cases are preventable and the American Heart Association's claim that 80% of strokes can be avoided.If you want a sharper brain by summer, this is your starting line. Subscribe, share this with someone you love, and leave a review telling us the one habit you'll change this week. Your future brain will thank you.Links:Majid Fotuhi, MD, PhD: https://drfotuhi.com/https://krieger.jhu.edu/mbi/directory/majid-fotuhi/https://neurogrow.com/about-us/dr-majid-fotuhi-md-phd/https://psychology.columbian.gwu.edu/majid-fotuhiTweet me @realdrhamrahIG @drhamrah

Episode 207: Understanding Hypertension and Diabetes (Pidjin English)Written by Michael Ozoemena, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.HypertensionSegment 1: What Is Hypertension?HOST:Let's start with the basics. Blood pressure is the force of blood pushing against the walls of your arteries. Think of it like water running through a garden hose—if the pressure stays too high for too long, that hose starts to wear out.Hypertension, or high blood pressure, means this pressure is consistently elevated. It is measured using two numbers:Systolic: the pressure when the heart beatsDiastolic: the pressure when the heart relaxesNormally reading is around 120/80 mmHg. Hypertension is defined by the American College of Cardiology/American Heart Association (ACC/AHA) as 130/80 mmHg or higher.The American Academy of Family Physicians (AAFP) defines hypertension as persistent elevation of systolic and/or diastolic blood pressure, with the diagnostic threshold for office-based measurement set at 140/90 mm Hg or higher.Segment 2: Why Should We Care?HOST:Hypertension is known as “the silent killer” because most people have no symptoms. Even without symptoms, it steadily increases the risk of:Heart attackStrokeKidney diseaseThink of high blood pressure as a constant stress test on your blood vessels. The longer it goes uncontrolled, the higher the chance of complications.Segment 3: What Causes High Blood Pressure?HOST:Hypertension usually doesn't have a single cause. It often results from a combination of genetic factors, lifestyle, and underlying medical conditions.Modifiable FactorsHigh-salt diet and low potassium intakePhysical inactivityTobacco useExcessive alcohol intakeOverweight or obesityChronic stressPoor sleep or sleep apneaNon-Modifiable FactorsFamily history of hypertensionBlack race (higher prevalence and severity)Age over 65Hypertension may also be secondary to other conditions, such as kidney disease, thyroid disorders, adrenal conditions, or medications like NSAIDs or steroids.Segment 4: How Is It Diagnosed?HOST:Diagnosis requires multiple elevated blood pressure readings taken on different occasions. This includes office readings, home blood pressure monitoring, or ambulatory blood pressure monitoring.If you haven't had your blood pressure checked recently, this is your reminder. It's simple—and it could save your life.Segment 5: Treatment and ManagementHOST:Lifestyle changes are often the first line of treatment:Reduce salt intakeEat more fruits, vegetables, and whole grainsAim for 150 minutes of moderate exercise per weekManage stressMaintain a healthy weightGet enough sleepLimit alcoholQuit smokingIf these steps aren't enough, medications may be necessary. These include:Diuretics, ACE inhibitors, ARBs, Calcium channel blockers, Beta-blockersYour healthcare provider will choose the best medication based on your health profile.Segment 6: What You Can Do TodayHOST:Here are three simple, actionable steps you can take right now:Check your blood pressure—at a clinic, pharmacy, or at home.Pay attention to your salt intake—much of it is hidden in processed foods.Move more—even a 20-minute daily walk can help reduce blood pressure over time.Small steps can lead to big, lasting improvements.SummaryHypertension may be silent but understanding it gives you power. Early action can add healthy years to your life. Take charge of your blood pressure today.Diabetes1. Wetin Diabetes Be and Wetin E Go Do to Person Body?Q: Wetin diabetes mean?A: Diabetes na sickness wey make sugar (glucose) for person blood too high. E happen because the body no fit produce insulin well, or the insulin wey e get no dey work as e suppose.Q: Wetin go happen if diabetes no dey treated well?A: If diabetes no dey treated well, e fit damage the blood vessels, nerves, kidneys, eyes, and even the heart.2. Wetin Cause Diabetes and Why Black People Suffer Pass?Q: Wetin cause diabetes?A: E no be one thing wey cause diabetes. E dey happen because of mix of gene, lifestyle, environment, and society factors.Q: Why Black/African Americans get diabetes more?A: Black people for America get diabetes more because of long-standing inequality, stress, low access to healthcare, and the kind environment wey many of them dey live in. These things dey make Black people more at risk.3. Diabetes Rates for America and Black People?Q: How many people get diabetes for America?A: For America today, over 38 million people get diabetes, and the number dey rise every year.Q: Why Black people dey suffer diabetes more than White people?A: About 12% of Black adults get diabetes, compared to just 7% for White adults. Black people also dey get the sickness earlier and e dey more severe.4. Signs and Symptoms of Diabetes?Q: Wetin be the early signs of diabetes?A: The early signs no too strong, but when e show, e fit include:Too much urine (polyuria)Thirst (polydipsia)Hunger, tiredness, and blurred visionWounds no dey heal fastTingling for hand or legSometimes weight loss5. How Doctor Go Diagnose Diabetes?Q: How doctor fit confirm say person get diabetes?A: Doctor go do some lab tests to confirm:Fasting Plasma Glucose (FPG): 126 mg/dL (7.0 mmol/L) or higherHbA1c: 6.5% or higher2-hour Oral Glucose Tolerance Test (OGTT): 200 mg/dL (11.1 mmol/L) or higher after person drink glucose.Random Blood Glucose: 200 mg/dL (11.1 mmol/L) or higher plus classic symptoms like too much urination, thirst, or weight loss.Q: Wetin happen if HbA1c test no match the person?A: If HbA1c result no match person symptoms, doctor fit repeat test or try other tests like FPG or OGTT.6. Wetin Screening and Early Diagnosis Fit Do?Q: Why screening for diabetes dey important?A: Screening dey important because early detection fit prevent serious complications from diabetes.Q: How often person go do diabetes test?A: Adults wey get overweight or obesity, between 35–70 years, suppose do diabetes screening every three years. But because Black adults get higher risk, doctors dey start screening earlier and more often.7. How Person Fit Manage Diabetes?Q: Wetin be the best way to manage diabetes?A: The two main ways to manage diabetes be:Lifestyle changes: Eat better food (vegetables, fruits, whole grain, beans, fish, chicken) and exercise regularly.Medicine: If person sugar still high, doctor fit give drugs like metformin, SGLT-2 inhibitors, or GLP-1 receptor agonists.Q: Wetin be SGLT-2 inhibitors and GLP-1 drugs?A: SGLT-2 inhibitors dey help with kidney and heart problems, while GLP-1 drugs dey help with weight loss and prevent stroke.Q: Wetin be first-line treatment for diabetes?A: First-line treatment for diabetes be metformin, unless person no fit tolerate am.Q: How much exercise a person suppose do?A: Person suppose do at least 150 minutes of moderate exercise per week. This fit include things like brisk walking, swimming, or cycling. E also good to add muscle-strength training two or three times weekly to help control sugar.Q: When insulin therapy go be needed?A: Insulin therapy go be needed if person A1c is higher than 10%, or if person dey hospitalized and their glucose dey above the 140-180 range. This go help bring the blood sugar down quickly.8. Wetin Be the Complications of Diabetes?Q: Wetin fit happen if diabetes no dey well-managed?A: Complications fit include kidney disease, blindness, nerve damage, leg ulcers, heart attack, stroke, and emotional issues like depression.Q: Why Black adults get more complications?A: Black people get higher risk of these complications because of inequality, stress, and poor access to healthcare.9. Wetin Dey Affect Access to Diabetes Treatment?Q: Wetin make Black people struggle to get treatment for diabetes?A: Many Black people no dey get new effective treatments like GLP-1 and SGLT-2 inhibitors because of price, insurance issues, and lack of access. COVID-19 also worsen things.Q: Wetin government and doctors fit do?A: Policymakers dey work on improving access to drugs, better community programs, and screening for social issues wey fit affect diabetes care.10. ConclusionQ: Wetin be the solution to reduce diabetes impact?A: The solution go need medical treatment, early screening, lifestyle support, and policy changes. With proper treatment and community support, e possible to reduce the impact of diabetes, especially for Black communities.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References: Whelton PK, Carey RM. Overview of hypertension in adults. UpToDate. 2024.Carey RM, Moran AE. Evaluation of hypertension. UpToDate. 2024.Mann SJ, Forman JP. Lifestyle modification in the management of hypertension. UpToDate. 2024.Giles TD, Weber MA. Initial pharmacologic therapy of hypertension. UpToDate. 2024.American Heart Association. Understanding Blood Pressure Readings. Accessed 2025.American Heart Association. AHA Dietary and Lifestyle Recommendations. Accessed 2025.Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.

We are joined by Kurt Bramer from Advanced CPR Solutions again this week to continue the series on Heads Up CPR and other promising sudden cardiac arrest treatments. He and Dr. Joe Holley kicked off the discussion in two previous episodes. Elevated CPR Series Episode One Elevated CPR Series Episdoe Two We open this week’s episode with a holiday severe weather update from our disaster meteorologist, Dan DePodwin. He reports on several storm systems that will impact Thanksgiving holiday travel across the eastern half of the country. Following that update, we kick off episode 3 of our heads-up CPR series with a look at the long history of the evolutionary changes to cardiac arrest treatment. Kurt Bramer from Advanced CPR Solutions leads off with a response to some comments to the first two episodes in this series. A few listeners worried that we might sound like we were criticizing the individual responders on cardiac arrest calls over the low survival rates for the condition. The team made a joint statement that no criticism of providers in the field was intended. We all are providers ourselves and are merely commenting on the results that everyone has been getting in response to treating cardiac arrest. Some systems do better with resource management than others, but even those areas fail to save even a simple majority of their cardiac arrest patients. CARES Registry for Cardiac Arrest Stats Follow up on more of these segments as we continue to look at the current research trends in future episodes and what is on the horizon for the future. The episode was co-hosted by Sam Bradley and Jamie Davis. Scroll down for Podcast Discussion Summary Thank you as always to Paragon Medical Education Group for their long-term support of the Disaster Podcast. Dr. Joe Holley and the team at Paragon continue to provide excellent and customized disaster response training to jurisdictions around the U.S. and internationally as well. Podcast Discussion Summary CPR Challenges and Future Improvements The meeting began with a discussion about travel weather for the Thanksgiving weekend, with Dan DePodwin warning of widespread lake effect snow in the eastern United States and a potential ground blizzard in the Dakotas and Minnesota. The group then transitioned to their main topic, CPR, where Joe clarified that their previous discussion about CPR’s limitations was not meant to criticize CPR providers, but rather to highlight the challenges and lack of progress in the field over the past 50 years. They planned to explore potential improvements to CPR in future episodes. Advancements in CPR Techniques Kurt Bramer, with 40 years of experience in EMS and emergency management, discussed the history of CPR, highlighting its evolution from mouth-to-mouth resuscitation to modern techniques. He emphasized the need for better tools and more effective methods for emergency responders, as current practices are often based on outdated or insufficiently tested techniques. The group acknowledged that while responders are doing their best with limited tools, recent research may lead to positive changes in CPR practices. They also touched on the introduction of high-performance CPR in the 2010s, which aimed to maximize the effectiveness of current technologies and minimize detrimental pauses during resuscitation efforts. Mechanical CPR Guidelines Review The discussion focused on the American Heart Association’s recent guidelines regarding mechanical CPR, which recommend against routine use but allow for exceptions like transport scenarios. Kurt and Joe highlighted that the guidelines lump together different types of mechanical compressors, ignoring their unique physiological effects and training limitations. They emphasized that current research primarily focuses on patient survival as an endpoint, which may not fully capture the benefits of mechanical CPR, such as improved blood flow and reduced pauses during resuscitation. The conversation also touched on the importance of considering neurological outcomes beyond mere survival and the need for better training on integrating mechanical devices into overall cardiac arrest management. Bundle Care Approach in Resuscitation The group discussed the bundle of care approach in resuscitation, focusing on the use of multiple therapies simultaneously to improve patient outcomes. Kurt and Joe highlighted the success of the ITD (Impedance Threshold Device) when used with high-quality CPR, leading to a 50% increase in one-year survival. They also noted that only a small percentage of resuscitation guidelines are supported by randomized control trials, emphasizing the challenges in interpreting research data. The group discussed the importance of disaster preparedness and the role of specialized training, with Jamie highlighting the sponsorship of the Disaster Podcast by Paragon Medical Education Group. Catch the full episode using the player above or on your favorite podcast platform, and don't forget to subscribe to the Disaster Podcast for weekly insights from leaders in disaster response and research!

Join us for Five Good Things with Janae Sharp and Megan Antonelli: A rapid-fire segment highlighting positive developments in digital health. Janae and Megan share insights on recent innovations, successful implementations, and emerging trends that are driving progress in healthcare technology.Janae Sharp, Founder & CEO, The Sharp IndexMegan Antonelli, Founder & CEO, HealthIMPACT Live

New weight loss drugs may portend end of “Fat Acceptance” movement; Celebs and Southerners embrace GLP-1s; Trump clears path for more access to diet drugs; Mid- and late-life exercise slash dementia risk; “Ethicists” urge more tick-borne meat allergy to save planet—as alpha-gal syndrome claims first fatality; What's wrong with the melatonin study that claims it leads to heart failure? How to detox 9-11 first-responders? Can weekend warriors obtain same benefits as regular exercisers? 

This is one in a series about possible futures, which will be published in Booch News over the coming weeks. Episode 6 appeared last week. New episodes drop every Friday. Introduction Legacy beverage corporations attempting hostile takeovers of kombucha startups failed to understand the living systems involved. Their sterile production methods eliminated beneficial microorganisms, while regulatory capture backfired as health authorities mandated probiotic content. Mega-Cola’s final CEO, James Morrison, desperately tried fermenting cola using SCOBYs, creating undrinkable disasters. This episode chronicles the corporation’s transformation from global giant to urban composting service, with former executives becoming mushroom farmers in Detroit’s abandoned factories. The $49 Billion Graveyard: When Giants Couldn’t Learn to Dance Harvard Business School’s legendary case study “The Mega-Cola Kombucha Catastrophe” became required reading for understanding how industrial thinking proved fatal in the biological economy. Between 2035 and 2042, legacy beverage corporations spent $48.7 billion attempting to acquire kombucha startups, only to discover that living systems couldn’t be purchased—they could only be cultivated. Mega-Cola’s acquisition spree began aggressively in 2035 under CEO James Morrison, a chemical engineer before ascending to the C-suite. He’d once loved the alchemy of bubbles and sweetness. His father had worked at a bottling plant; he’d grown up thinking carbonation was progress. He viewed kombucha as merely another “disruption” to be absorbed and had become a champion of “hydration portfolios”—a polite euphemism for diversifying out of soda into teas, waters, and ferments. The company spent $12.7 billion acquiring 47 kombucha brands, from market leader Health-Ade to smaller artisanal producers like Portland’s Brew Dr Kombucha. Morrison’s strategy seemed logical: leverage Mega-Cola’s distribution network and manufacturing scale to dominate the emerging probiotic market. The Sterilization Disaster The first catastrophic failure occurred when Mega-Cola attempted to scale Humm Kombucha production at its Oregon facility. Morrison stood before a 10,000-gallon fermentation tank—ten times the size of any used by the acquired kombucha companies. Chief Science Officer Dr. Hiram Walsh explained the modifications they’d made. “We’ve adapted our quality control protocols from our soft drink lines,” Walsh said proudly. “Every input is filtered, pasteurized, and chemically treated. We’ve eliminated 99.9% of microbial contamination risk.” Walsh pulled up charts showing their testing results. “Batch consistency is perfect. Zero deviation. Every bottle identical.” Morrison smiled. “Exactly what we wanted. When do we start distribution?” “Next week,” Walsh confirmed. “We’re calling it MegaBucha. Focus groups love the name.” One week later, Morrison sat in an emergency meeting. The first consumer feedback was catastrophic. Walsh read from report after report: “‘Tastes like carbonated vinegar.’ ‘Chemical aftertaste.’ ‘Nothing like real kombucha.’ ‘Dead and flat.’ Return rates are 87%.” Walsh looked confused. “I don't understand it. The bacteria counts are perfect. We followed their recipes exactly.” On the teleconference screen, Health-Ade founder Vanessa Dew shook her head. “You killed it. Your ‘quality control’ eliminated every living organism. Kombucha isn’t about sterility—it’s about controlled biological diversity. You can’t pasteurize and filter kombucha and expect it to remain the same. You’ve simply made acidic sugar water.” Morrison spluttered, “We spent $2.1 billion acquiring your company. We’re not walking away because of ‘quality control’ issues.” “It’s not quality control—it’s biology,” Vanessa explained. “Kombucha cultures need biodiversity to thrive. Your system is built to prevent exactly that.” Morrison’s jaw tightened. “Then we’ll adjust the process. Keep some bacteria alive.” Vanessa sighed. “Your entire facility is designed to kill microbes. Your pipes, your tanks, your air filtration, your worker protocols—everything optimized for sterility. You’d have to rebuild from scratch. And even then, you’d need to fundamentally rethink how you approach production. Living systems don’t work like machines.” The company had overlooked the success of the UK’s ROBOT Kombucha, the “A.I. Cola” replicated cola’s taste in a fermented drink, becoming the beverage of choice for adults who had first tasted it as teenagers when it was introduced in 2025. Founder Pascal du Bois had selected his ingredients from a range of different organic botanicals from which the flavor was extracted. He then created a complex blend of more than a dozen types of bacteria and four strains of organic yeast. After fermenting for seven weeks they add a teaspoon of 100% organic honey, sourced from France, to each can. This mimics the familiar cola taste without added sugars or aspartame. The result was a healthy alternative designed to appeal to cola lovers, not a standardized Frankenbooch. Dr. Kenji Nakamura—the former Genentech researcher who later founded the Eastridge Mall Kollective—was hired as a $5 million consultant to solve the Mega-Cola problem. His report sat on Morrison’s desk—200 pages detailing why Mega-Cola’s approach couldn’t work. “I’ll cut to the conclusion,” Nakamura said. “Your industrial infrastructure is fundamentally incompatible with living beverages. Your entire supply chain is designed to kill exactly what makes kombucha valuable.” Morrison leaned forward. “We paid you to find solutions, not problems.” “The solution is accepting that some things can’t be industrialized,” Nakamura replied calmly. “Kombucha succeeds because of microbial relationships that develop over time through careful cultivation. You’re trying to force-manufacture relationships. It’s like trying to raise children in a morgue—the environment is hostile to life. Your kombucha tastes bad because you’ve optimized the life out of it. You can’t ‘optimize’ life—you can only cultivate it.” Mega-Cola CFO Samantha Chen pulled up financial projections. “We’ve now spent $14.8 billion on kombucha acquisitions and infrastructure. We need to either make this work or write off the entire investment.” Nakamura shook his head. “Every dollar you spend trying to industrialize kombucha is wasted. The companies you acquired succeeded because they were small—they could maintain microbial diversity, respond to batch variation, cultivate living systems. Scale destroys those advantages.” Morrison’s face reddened. “Are you telling me that a bunch of hippies in Portland can do something Mega-Cola, with our resources and expertise, cannot?” “Yes,” Nakamura said simply. “Because they’re not trying to dominate biology. They’re partnering with it. Your entire corporate culture is about control, optimization, standardization. Living systems require adaptation, diversity, patience. Those are fundamentally incompatible approaches.” Morrison stood. “We’ll find someone else. Someone who can make this work.” Nakamura gathered his materials. “You’ll spend millions more reaching the same conclusion. Biology doesn’t care about your quarterly earnings or your market cap. You can’t buy your way out of this.” After Nakamura left, Morrison and Chen sat in silence. Chen finally spoke. “He’s right, you know.” Morrison didn’t respond. The Regulatory Trap: When Capture Became Captivity Legacy corporations had initially celebrated the FDA’s Probiotic Verification Act of 2038, which they had lobbied for extensively. The law required all “live beverage” products to contain minimum concentrations of beneficial bacteria, verified through independent testing. Mega-Cola’s legal team believed this would create barriers for small producers while giving large corporations with deep pockets competitive advantages through regulatory compliance costs. The strategy backfired catastrophically. While artisanal kombucha producers thrived under the new standards—their naturally diverse microbial ecosystems easily exceeded requirements—corporate products consistently failed testing. Mega-Cola spent $20 million on fermentation consultants and biotechnology acquisitions, but its sterile facilities couldn’t maintain the mandated bacterial diversity. Meanwhile, in the company boardroom, a tense meeting took place. Chen read the headline from a Wall Street Journal article: “Mega-Cola’s ‘Kombucha’ Contains Fewer Probiotics Than Yogurt, FDA Testing Reveals.“ Morrison stared at the headline. “How did this happen?” “Our sterilization processes,” Walsh admitted. “We can’t maintain bacterial counts through our production and distribution systems. The small producers can because they’re working with robust, diverse cultures in small batches. We’re working with weakened, standardized cultures in massive volumes. The bacteria die.” The legal counsel shifted uncomfortably. “The regulation we pushed for is now our biggest problem. We can’t legally call our product kombucha. We could petition the FDA to lower the standards—” Morrison’s voice was quiet. “How much have we spent trying to fix this?” Chen checked her tablet. “$20.3 million on fermentation consultants and biotechnology acquisitions. None of it worked.” The Medical Tsunami: Soda as Poison By 2040, the medical evidence against sugar-laden sodas had become overwhelming. The American Heart Association officially classified high-fructose corn syrup as a “Class II toxin,” requiring warning labels similar to tobacco. The crisis came to a head when the Journal of the American Heart Association published “The Corporate Diabetes Epidemic: A Century of Metabolic Warfare” in 2041. The paper demonstrated that diabetes and obesity rates directly correlated with Mega-Cola’s market penetration across 147 countries. Areas with higher Cola consumption showed disease patterns resembling chemical contamination rather than natural illness. Dr. Harold Lustig presented twenty years of longitudinal research to a packed auditorium. The screen behind him showed stark data: “Regular soda consumption increases diabetes risk by 340%. It shortens lifespan by an average of 7.4 years. We’re officially classifying high-fructose corn syrup as a Class II toxin, requiring warning labels similar to tobacco.” Mega-Cola CEO Morrison watched from the back. His phone buzzed constantly—board members, investors, media requesting comment. Lustig continued: “Children who drink one soda daily show measurable delays in brain development compared to peers consuming fermented beverages. Brain imaging reveals high-fructose corn syrup literally shrinks the prefrontal cortex.” A reporter raised his hand. “Are you saying soda causes brain damage?” “I’m saying the evidence strongly suggests regular soda consumption impairs cognitive development,” Lustig responded. “Meanwhile, children consuming diverse fermented foods show superior health outcomes across every metric we measured.” Morrison left before the Q&A. In the hallway, CFO Chen was waiting. “The stock dropped 12% during the presentation,” she said quietly. “Investors are calling soda ‘the new tobacco.'” Morrison stared out the window at the Washington Monument. “We knew sugar was problematic. We’ve been reformulating—” “It’s not just sugar,” Chen interrupted. “It’s the entire category. Industrial beverages versus living fermentation. We’re on the wrong side.” “We’re a $300 billion company,” Morrison said. “We can’t just pivot to kombucha. We tried that. It failed.” Chen’s voice was gentle but firm. “Then maybe we need to accept that some companies don’t survive paradigm shifts.” The Educational Exodus: Schools Declare War on Soda The Los Angeles Unified School District’s vote to ban all non-fermented beverages in schools attracted phalanxes of Mega-Cola lobbyists and lawyers. A Mega-Cola representative presented their case: “Banning our beverages punishes students from low-income families who can’t afford expensive alternatives. We’re prepared to offer healthier formulations—” A parent cut him off. “You’ve been promising ‘healthier formulations’ for thirty years while marketing addictive sugar-water to our children.” Dr. Rebecca Scharf's groundbreaking research demonstrated that children who were given an alternative to sugar-sweetened soda were healthier. The school district called her as an expert witness. She summarized her findings: “Two years after schools switched to kombucha dispensaries with on-campus fermentation labs, we see 67% reduction in behavioral problems, 45% improvement in test scores, 89% decrease in childhood obesity.” A high school student approached the microphone. “I’m sixteen. I grew up drinking your soda. I was diagnosed with pre-diabetes at fourteen. Since switching to fermented beverages, my health has improved. But my little brother is eight—he’s never had soda, only fermentation. He’s healthier than I ever was. You took my health. Don’t take his.” By 2052, 43 states had implemented similar bans. The “Fermentation Generation”—children who grew up drinking school-provided kombucha—showed dramatically superior health outcomes compared to predecessors who consumed soda. These children literally rejected Mega-Cola on a physiological level; their optimized gut microbiomes found industrial beverages repulsive. Medical Prescriptions Against Corporate Beverages The American Academy of Pediatrics’ 2044 guidelines required doctors to “prescribe against” soda consumption, treating it as seriously as smoking cessation recommendations. Insurance companies began covering kombucha prescriptions while penalizing patients who tested positive for high-fructose corn syrup consumption. Dr. Chen’s research (detailed in Episode 2) provided the scientific foundation for these medical interventions. Her studies proved that even occasional soda consumption disrupted the personalized gut microbiomes that enabled optimal cognitive function. Doctors began prescribing specific kombucha strains to repair metabolic damage caused by years of consuming industrial beverages. Morrison’s Tower Disaster: Industrial Control Meets Living Systems Following his 2050 visit to Aberdeen’s agricultural tower, Morrison commissioned twelve “MegaTower” facilities across North America, investing $8.4 billion in what he called “industrial-scale fermentation infrastructure.” His engineers replicated the physical structure perfectly—1,200-meter climate-controlled spires with alternating tea cultivation and kombucha production floors. The catastrophe unfolded within months. Morrison’s towers, designed for efficiency optimization, automated every process that Aberdeen’s workers performed intuitively. Computer algorithms regulated temperature, humidity, and nutrient delivery with microsecond precision, eliminating “human inefficiency.” The tea plants withered. The SCOBYs died. Dr. MacLeod’s warnings proved prophetic: Morrison had copied the machinery while killing the ecosystem. His sterile protocols eliminated the beneficial fungi, bacteria, and insects that made Aberdeen’s floors function as living environments. His “optimized” nutrient solutions lacked the complexity of naturally composting tea waste. His automated systems couldn’t respond to the subtle biological cues that experienced cultivators recognized instinctively. By 2053, all twelve MegaTowers stood empty—$8.4 billion monuments to the fundamental incompatibility between industrial control and biological partnership. The failure accelerated Mega-Cola’s eventual bankruptcy, proving that living systems cannot be purchased; they can only be cultivated. Morrison’s Desperate Gambit: Fermented Cola Stung by his failed “MegaTower” experiments, Morrison staked Mega-Cola’s survival on developing fermented cola using modified SCOBYs. The “New Cola Kombucha” project consumed $67 million over three years, employing thousands of microbiologists and fermentation specialists. The results were universally catastrophic. Dr. Park, a fermentation specialist hired from Korea, led Morrison through the lab. Rows of fermentation vessels bubbled with dark liquid. Scientists monitored bacterial counts, pH levels, sugar content. “We’ve engineered SCOBY cultures that can ferment in the presence of cola flavorings,” Park explained. “It’s taken three years, but we have a stable culture.” Morrison looked hopeful for the first time in years. “And it tastes good?” Park hesitated. “It tastes… interesting.” They entered a tasting room where twenty focus group participants sat with cups of dark, fizzy liquid. Morrison watched through one-way glass as participants tasted the fermented cola. The reactions were immediate and universal: grimacing, coughing, one person actually gagged. “Fizzy coffee grounds mixed with cleaning products,” one person said. “Like someone fermented tire rubber,” another offered. “I think I can taste failure,” a third concluded. Park pulled Morrison aside. “The SCOBY cultures are stressed by the chemical additives in cola formulation. They’re producing unusual compounds—not toxic, exactly, but profoundly unpleasant. They’re causing gastrointestinal distress in 89% of test subjects.” Morrison stared at the focus group, then turned to Park. “Give me options. Can we adjust the flavor profile? Different additives?” “We’ve tried 47 formulations,” Park explained. “The problem isn’t the recipe—it’s the fundamental incompatibility between cola chemistry and healthy fermentation at this scale. The bacteria are literally stressed by the environment we’re asking them to live in.” “So what you’re telling me is that fermented cola is impossible?” Park hesitated. “I’m telling you that your version of fermented cola—one that tastes like Mega-Cola but contains living bacteria—is impossible. If you were willing to let go of the cola formula entirely and create something new…” “Then it wouldn’t be Mega-Cola,” Morrison insisted. “That’s what I’m trying to save.” Morrison sank into a chair. “How much have we spent on this?” “$67 million,” Park confirmed. “And it’s undrinkable.” “Yes.” Morrison laughed bitterly. “We can put a man on Mars, but we can’t ferment cola.” Park’s voice was kind. “We can’t ferment cola because we’re trying to put it on Mars. Fermentation requires accepting biology on its own terms. We keep trying to force it into our industrial model. Biology keeps refusing.” The FDA’s emergency recall of Morrison’s prototype batches in 2059 triggered the final collapse of investor confidence. The Bankruptcy Cascade: Industrial Liquidation Mega-Cola declared bankruptcy on November 1, 2060—the Mexican Day of the Dead seemed grimly appropriate for the death of an American institution. The company’s $284 billion in debts exceeded its assets by a factor of three, as brand value evaporated alongside consumer demand. The company was not alone. BigSoda collapsed six months later, then Dr Gipper —the third-ranking cola in the world —creating a cascade of corporate failures worth over $1.2 trillion. Morrison sat alone in his office as the board meeting proceeded via video conference. The board chair spoke: “The FDA has issued an emergency recall of all New Cola Kombucha prototypes after test subjects required hospitalization. Our stock price has fallen 89% from its peak. Our debt exceeds assets. We have no choice.” Morrison knew what he must announce. “Mega-Cola Corporation is filing for Chapter 11 bankruptcy protection, effective immediately.” On screens across America, news anchors delivered the story. Morrison watched employees leave the building carrying boxes. Fifty thousand jobs ending. A century-old brand dying. Chen entered his office quietly. “I’m sorry, James.” Morrison didn’t turn from the window. “You tried to warn me. Back in 2035. You asked if we could industrialize biology without killing what made it valuable.” “I did.” “The answer was no.” “I guess I just didn't listen.” Morrison was quiet for a long moment. “I spent my whole career optimizing systems, maximizing efficiency, scaling operations. I was good at it. But biology doesn’t care about efficiency. It cares about diversity, resilience, relationships. Everything I knew how to do was wrong for this.” Chen sat beside him. “What will you do now?” Morrison laughed without humor. “I’m 62 years old. My entire career has been corporate optimization. I don’t know how to do anything else.” “You could learn,” Chen suggested. “Learn what?” Morrison asked. “How to brew kombucha in my garage? I destroyed people’s livelihoods trying to industrialize something that shouldn’t be industrialized. I don’t deserve to be part of what comes next.” “Maybe that’s exactly why you should be,” Chen said softly. “You understand what doesn’t work. That’s valuable knowledge.” The liquidation auctions became symbols of industrial obsolescence. Mega-Cola’s Detroit headquarters sold for $47 million to the Georgia Fermentation Kollective, which converted the building into vertical kombucha gardens. The iconic “Land of Cola” museum became the “Museum of Metabolic Harm,” displaying artifacts from humanity’s sugar-addiction era alongside warnings about corporate food manipulation. Urban Composting: From Soda to Soil Morrison’s personal transformation paralleled that of his company. After Mega-Cola’s bankruptcy, he founded “Regenerative Detroit,” converting abandoned bottling plants into urban composting facilities that produced soil for vertical tea gardens. His memoir, From Syrup to SCOBY: A CEO’s Redemption, became a bestseller, chronicling his journey from corporate predator to ecological steward. Nakamura, the consultant who told Morrison his approach would fail, visited the facility. “You were right,” Morrison said without preamble. “Everything you said in that meeting. I spent five more years and hundreds of millions trying to prove you wrong, only to end up proving you right.” Nakamura watched Morrison teach a teenage girl how to inoculate a growing medium with mushroom spores. “This is unexpected. I thought you’d retire to a beach somewhere, try to forget.” Morrison laughed. “I tried that for six months. I was miserable. Spent forty years destroying things. Figured I should spend whatever time I have left trying to build something.” “Why composting?” “Because it’s the opposite of what I did at Mega-Cola,” Morrison explained. “There, we tried to force sterility, eliminate variability, control every process. Here, we cultivate diversity, encourage complexity, work with biological systems rather than against them. We take waste and transform it into something useful. It’s… healing, I guess.” A teenager approached. “Mr. Morrison, my mushrooms are growing!” Morrison’s face lit up. “Let me see!” He examined her cultivation tray with genuine excitement. “Beautiful! You maintained perfect humidity. These will be ready to harvest in two weeks.” After the children left for lunch, Nakamura and Morrison walked through the facility. “How many people work here?” Nakamura asked. “Forty-seven,” Morrison responded. “Thirty-two are former Mega-Cola employees. When the company collapsed, they lost everything. I felt responsible. So I used what was left of my savings to buy this facility and train them in regenerative agriculture.” “And the composting is profitable?” Morrison shrugged. “We break even. Barely. But that’s not really the point. The point is transforming industrial waste into living soil. The point is teaching the next generation that decay isn’t the enemy—it’s the beginning of new life. The point is learning to think like an ecosystem instead of a corporation.” They stopped before a wall displaying Morrison’s memoir: From Syrup to SCOBY: A CEO’s Redemption. “I read your book,” Nakamura said. “Brutal self-assessment.” “Had to be,” Morrison replied. “I spent decades helping build a system that made billions by making people sick. If I’m going to do anything meaningful with the rest of my life, I need to be honest about what I did wrong.” Nakamura gave him a piercing look. “What’s the hardest lesson, James?” Morrison thought for a moment. “That you can’t buy relationships. Mega-Cola tried to purchase kombucha companies and force them into our industrial model. But the reason those companies succeeded was because they maintained living relationships—between bacteria, between brewers and their cultures, between producers and customers. We thought we could commodify those relationships. We were wrong.” Nakamura looked into the other man’s eyes. “Do you regret your career at Mega-Cola?” “Every day,” Morrison said. “But regret without action is just self-pity. I can’t undo the harm I caused. I can only try to spend whatever time I have left doing things differently.” The two men stood silent. “And now?” Nakamura eventually asked. “Now I’m learning that the same principle applies to everything. Healthy soil requires relationships between millions of organisms. Healthy communities require relationships between people. You can’t manufacture relationships. You can only cultivate them.” A former Mega-Cola executive, now managing the composting operation, approached. “James, the new batch is ready. Want to check it?” They walked to a massive composting area where industrial waste had been transformed into rich, dark soil. Morrison picked up a handful, letting it sift through his fingers. “Five years ago, I couldn’t have told you what healthy soil looked like. Now I can diagnose it by touch, smell, and sight. I know the difference between soil that’s alive and soil that’s dead. I wish I’d learned that forty years ago.” Business School Autopsies: Failed Integration Studies Mega-Cola’s failed acquisitions became business school case studies teaching a fundamental lesson about the new economy: you couldn’t buy biological relationships, only nurture them. Companies that thrived in the fermentation future were those that learned to think like ecosystems rather than machines, valuing symbiosis over extraction and cooperation over control. The old extraction-based capitalism of brands, advertisements, and artificial scarcity had dissolved in the acid of transparency. In its place rose a commerce of connection, a network of exchange based on trust, craft, and living value. No one “sold” kombucha anymore. They shared it—encoded with local identity, story, and microbial lineage. Each brew was a living signature, traceable back to the brewer’s SCOBY ancestry through transparent bio-ledgers—open microbial blockchains that recorded not profits, but relationships. Harvard Business School’s legendary case study “The Mega-Cola Kombucha Catastrophe” had become required reading for understanding how industrial thinking fails when confronting biological complexity. Professor George Santos—a reformed fraudster turned champion of ethical business studies at Harvard—projected key figures on his classroom screen summarizing the Mega-Cola meltdown: $48.7 billion spent on kombucha acquisitions and infrastructure Zero successful products launched 94% loss of beneficial bacteria in acquired brands Complete corporate collapse within 15 years Morrison sat in the audience, invited as a guest speaker. The students didn’t know he was there yet. Santos lectured: “Mega-Cola’s failure wasn’t about lack of resources or expertise. They had the best food scientists, unlimited capital, and a dominant market position. They failed because they tried to apply industrial logic to biological relationships. It’s a category error—treating living systems like machines.” A student raised her hand. “But couldn’t they have just left the kombucha companies independent? Kept them small-scale?” “Good question,” Santos responded. “But that would have defeated the purpose of the acquisition. Morrison wanted to leverage industrial efficiency to dominate the market. He couldn’t accept that efficiency itself was the problem.” “Sounds arrogant,” another student said. “It was,” Morrison spoke from the audience. “Unforgivably arrogant.” The room went silent as students realized who he was. Santos smiled. “Class, we have a special guest. Mr. Morrison has agreed to discuss his decisions and their consequences.” Morrison walked to the front slowly. At 72, he looked older than his years. “I’m here because Professor Santos asked me to help you understand how intelligent, well-intentioned people can make catastrophic mistakes,” Morrison began. “In 2035, I was confident, even cocky, firmly believing we could apply our industrial processes to kombucha. I have degrees from Wharton and McKinsey experience. I’d successfully optimized dozens of operations. I didn’t see kombucha as a challenge—I saw it as an opportunity.” “What changed?” a student asked. “Repeated failure,” Morrison said simply. “We acquired kombucha brands. We killed them by trying to scale them. We hired consultants. They told us what we were doing wrong. We didn’t listen. We tried to ferment cola using SCOBYs. We created undrinkable disasters. Eventually, even I couldn’t ignore reality: you can’t industrialize living relationships.” “Why not?” another student challenged. “We industrialize lots of biological processes. Agriculture, pharmaceuticals—” “Different scale, different complexity,” Morrison explained. “Kombucha requires dozens of organisms in complex relationships. You can’t standardize that without destroying what makes it work. And more fundamentally, I didn’t respect what I was trying to control. I saw bacteria as inputs to be optimized, not as living partners to be cultivated. That disrespect guaranteed failure.” Samantha Chen, sitting in the back, spoke up. “I was Mega-Cola’s CFO. I warned James from the beginning that we were trying to commodify relationships. He didn’t listen until we’d burned through billions and destroyed the brands we’d acquired. The lesson isn’t just about fermentation—it’s about recognizing when your core competencies are incompatible with what you’re attempting.” A student asked the obvious question: “Mr. Morrison, you lost billions of dollars and collapsed a century-old company. Why should we listen to you?” Morrison smiled sadly. “Because I failed spectacularly at something many of you will attempt: forcing biological systems into industrial models. Climate change, environmental restoration, and sustainable agriculture—you’ll all face situations where industrial thinking fails. If hearing about my failures helps even one of you recognize that trap earlier, then bankrupting Mega-Cola will have served some purpose.” Cola Coda The demise of Mega-Cola and Morrison's redemption was celebrated in song by a young group of Baltimore kombucha brewers whose anthem ‘It's an Unreal Thing' was played on college radio stations by retro-70's leather-jacketed DJ's with pierced ears. Here’s Hexotronix: Go now, take what you think will lastBut whatever you wish to keep, you better grab it fastAll your failed investments, they’re all going homeYour fermentation formula had the wrong biomeYour scientists who just walked out the doorHave taken all their SCOBYs from the brewery floorThe towers too have failed to come throughAnd now it's time to go find something new. [Chorus]You sold your soda to a worldThat you thought you'd taught to singIn perfect harmonyBut it's an unreal thing, an unreal thing. You bought up all our breweries, didn't you?Your fake fermented drinks just didn't come through .You killed what made kombucha realSo how does it feelTo be completely unreal?How does it feelTo be a joker?How does it feelTo be a bankrupt, down at heel?With the whole world laughingAt your soda? [Chorus] Your beverage was a bustYour dreams all turned to dustThe missing partWas our SCOBY heartRight there at the startBut you didn't seeWhat we sawDidn't feelWhat we feltDidn't knowWhat we knewDidn't loveWhat we loved. [Chorus] Leave your corporate life behind, something calls for youThe dream that you once had is clearly through.Forget the drinks you've served, they will not follow youGo tell another story start anewThe compost and mushrooms, they now call to you. [Chorus] Epilogue: The Next Discovery Morrison’s transformation from CEO to mushroom farmer illustrates that recognizing failure honestly opens paths to genuine learning. His redemption isn’t about success—it’s about accepting that some approaches are fundamentally wrong and committing to something different. However, one man’s transformation was only the beginning. While corporate executives struggled to understand living systems, a brilliant citizen scientist was making discoveries that would prove the human brain itself required biological partnerships to reach its full potential. Check back next Friday as the gripping tale of ‘Our Fermented Future’ continues. Disclaimer This is a work of speculative fiction. Names, characters, businesses, events, and incidents are the product of the author's imagination, assisted by generative A.I. References to real brands and organizations are used in a wholly imaginative context and are not intended to reflect any actual facts or opinions related to them. No assertions or statements in this post should be interpreted as true or factual. Audio Listen to an audio version of this Episode and all future ones via the Booch News channel on Spotify, Apple Podcasts, or wherever you get your podcasts. If you just want to listen to the music (classic 80’s punk!) tune in as follows: Hexotronix, It’s an Unreal Thing, 36:17 Lyrics ©2025 Booch News, music generated with the assistance of Suno. The post Our Fermented Future, Episode 7: Corporate Death Spiral—How Cola Became Compost appeared first on 'Booch News.

Amniotic fluid embolism (AFE) is life-threatening, unpredictable, sudden, and complex. Miranda Klassen and Kayleigh Summers are two remarkable survivors and leading voices in AFE advocacy, education, and research. In this episode, they describe their life changing experiences, reflect on how AFE can impact nurses and other health care professionals, and share their mission driven work to heal. Immerse yourself in this episode in order to connect with the tools and resources you need to prepare for an AFE or to support survivors. Meet our guests: Miranda Klassen, BSc Read More Miranda Klassen is the Executive Director of the Amniotic Fluid Embolism Foundation, a non-profit organization she founded in 2008, after surviving an AFE during the birth of her son. Miranda is also a co-investigator for the Amniotic Fluid Embolism Registry and Biorepository and has authored several publications on AFE and support after a severe maternal event. She is a frequent lecturer and serves on multiple boards and maternal health initiatives. She lives in San Diego, CA, with her husband Bryce, a critical care nurse, and their son, Van. Kayleigh Summers, LCSW, PMH-C Read More Kayleigh Summers is a licensed therapist, writer, and content expert in perinatal trauma. Drawing from her clinical expertise and lived experience as an amniotic fluid embolism survivor, Kayleigh is dedicated to supporting families navigating perinatal trauma and collaborating with healthcare institutions to implement trauma-informed care tailored to pregnant and postpartum populations. As The Birth Trauma Mama, Kayleigh has cultivated vibrant support communities through Instagram, TikTok, and her podcast, offering connection, storytelling, and valuable resources for individuals impacted by perinatal trauma. Her work bridges clinical knowledge and personal insight, fostering hope and healing for those in need. Episode Resources Amniotic Fluid Embolism Foundation  Crisis Hotline Call: 1-307-363-2337 (1-307-END-AFES)  Course: Amniotic Fluid Embolism: A Practical Approach  AFE Effective Communication Guide  Klassen, M., Summers, K. (2025). Effective communication during and after an amniotic fluid embolism. MCN. The American Journal of Maternal Child Nursing, 50(5), 269-276. doi: 10.1097/NMC.0000000000001121.  AFE Management and Treatment  Pacheco, L. D., Clark, S. M., Fox, K., Bauer, M. E., & Clark, S. L. (2025). Use of atropine, ondansetron, and ketorolac in suspected amniotic fluid embolism. Obstetrics and Gynecology.  doi: 10.1097/AOG.0000000000006095.  Cao, D., Arens, A. M., Chow, S. L., Easter, S. R., Hoffman, R. S., Lagina, III, A. T., Lavonas, E. J., Patil, K. D., Sutherland, L. D., Tijssen, J. A., Wang, G. S., Zelop, C. M., Rodriguez, A. J., Drennan, I. R., & McBride, M. E. (2025). Part 10: Adult and pediatric special circumstances of resuscitation: 2025 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation, 152(suppl 2), S578–S672. doi: 10.1161/CIR.0000000000001380.  Ripoll, J. G., Kahn-Pascual, Y. O., Seelhammer, T. G., Bittner, E. A., Chang, M. G., Ortoleva, J., Soto, J. C. D., Elmadhoun, O., Naoum, E. E., Wieruszewski, P. M., Nabzdyk, C. G., & Ramakrishna, H. (2025). ECMO in pregnancy: Analysis of indications, management and outcomes. Journal of Cardiothoracic and Vascular Anesthesia. https://doi.org/10.1053/j.jvca.2025.08.030.  The Birth Trauma Mama Podcast  Holding Hope Perinatal   Documentary: 24 Days Without You  Postpartum Support International: Karen Kleinman's Postpartum Stress Center  Preeclampsia Foundation  Eye Movement Desensitization and Reprocessing (EMDR) Theory       The post Understanding AFE: A Dual Survivor Perspective appeared first on AWHONN.

Volunteering makes an immeasurable difference in the lives of volunteers and those they help. Many people may be surprised to learn how positive volunteering can be for volunteers. Indeed, studies show that volunteering leads to better physical and mental health, among other benefits. According to an article published by the American Heart Association and Jeffrey Burr, a professor of gerontology at the University of Massachusetts Boston, “compared to non-volunteers, volunteers have less depression, less anxiety, higher self-esteem, greater happiness, and a greater sense of meaning in life.” Burr and the AHA note the health benefits of volunteering occur among all...Article Link

Send us a textAccording to the American Heart Association, Afib affects an estimated 5 million Americans today, and 12 million are projected to have it by 2030. Returning to the podcast to discuss Atrial Fibrillation is Dr. Talha Farid, cardiologist with St. Luke's Heart Care Clinic. To learn more about heart care services at St. Luke's Hospital, visit unitypoint.org/cr-heart.Do you have a question about a trending medical topic? Ask Dr. Arnold! Submit your question and it may be answered by Dr. Arnold on the podcast! Submit your questions at: https://www.unitypoint.org/cedarrapids/submit-a-question-for-the-mailbag.aspxIf you have a topic you'd like Dr. Arnold to discuss with a guest on the podcast, shoot us an email at stlukescr@unitypoint.org.

This week, Dr. Kahn provides details on presentations just made and published at the annual scientific meeting of the American Heart Association in New Orleans. Topics include a polypill for heart failure, coffee for atrial fibrillation, an oral PCSK9 inhibitor, beta-blockers after heart attacks, gene editing to lower cholesterol, and the use of PCSK9 inhibitors (Repatha) in a randomized trial of patients at risk for heart attack and stroke.  Dr. Kahn also reviews the role of lycopene in preventing prostate cancer (think tomatoes), colchicine in heart patients, the power of combining statins with ezetimibe, earlier mitral valve repairs, and new data suggesting that drugs like tadalafil (Cialis) may reduce the risk of death and dementia.  Dr. Kahn thanks tryauri.com/drkahn for their support and discount for listeners of Heart Doc VIP.

For more than six decades, the Phoenix Heart Ball has brought our community together to raise critical funds and awareness for the American Heart Association — an organization that's been fighting heart disease and stroke for over 100 years. This year marks the 66th Annual Phoenix Heart Ball, happening November 22, 2025, and it's a celebration of generosity, research, and the people whose dedication keeps every heart beating stronger. Joining me today are Sue Carter and Caroline Conner, both serving as Vice Chairs for this year's Heart Ball. Sue and Caroline are deeply connected to this cause — each with personal family experiences that inspire their passion for advancing heart health — and they're here to share what makes this year's event so meaningful. Calendar of Events Scottsdazzle's Tinsel Trail  Scottsdale is adding even more sparkle to the holidays with its first-ever Tinsel Trail, part of this year's Scottsdazzle celebration. Local artists will transform Old Town storefronts into festive works of art from November 14th - 24th  creating a self-guided holiday window tour for everyone to enjoy from November 29- December 31st Visitors can stroll the trail, meet the artists through an online map, and even vote for their favorite display.   Visit https://scottsdazzle.com/ for more.   Holiday Lights 2025 At McCormick Stillman Railroad Park in Scottsdale November 28 - December 30 The park transforms into a sparkling winter wonderland filled with twinkling lights and festive displays. Hop on the Charros Carousel, soak up the holiday magic, and warm up with a cozy cup of hot cocoa from Hartley's General Store.   https://www.therailroadpark.com/event/holiday-lights/   Vineyards in the Valley  Saturday, December 6th at the Charro Lodge in Scottsdale Stadium.  The event features wines from over 70 ultra-premium, highly allocated wineries from Sonoma and Napa Regions, curated gourmet food pairings, entertainment, and a charity auction — all in support of life-saving health services for women and children in southern Haiti.   VineyardsInTheValley.org.  

For more than six decades, the Phoenix Heart Ball has brought our community together to raise critical funds and awareness for the American Heart Association — an organization that's been fighting heart disease and stroke for over 100 years. This year marks the 66th Annual Phoenix Heart Ball, happening November 22, 2025, and it's a celebration of generosity, research, and the people whose dedication keeps every heart beating stronger. Joining me today are Sue Carter and Caroline Conner, both serving as Vice Chairs for this year's Heart Ball. Sue and Caroline are deeply connected to this cause — each with personal family experiences that inspire their passion for advancing heart health — and they're here to share what makes this year's event so meaningful. Calendar of Events Scottsdazzle's Tinsel Trail  Scottsdale is adding even more sparkle to the holidays with its first-ever Tinsel Trail, part of this year's Scottsdazzle celebration. Local artists will transform Old Town storefronts into festive works of art from November 14th - 24th  creating a self-guided holiday window tour for everyone to enjoy from November 29- December 31st Visitors can stroll the trail, meet the artists through an online map, and even vote for their favorite display.   Visit https://scottsdazzle.com/ for more.   Holiday Lights 2025 At McCormick Stillman Railroad Park in Scottsdale November 28 - December 30 The park transforms into a sparkling winter wonderland filled with twinkling lights and festive displays. Hop on the Charros Carousel, soak up the holiday magic, and warm up with a cozy cup of hot cocoa from Hartley's General Store.   https://www.therailroadpark.com/event/holiday-lights/   Vineyards in the Valley  Saturday, December 6th at the Charro Lodge in Scottsdale Stadium.  The event features wines from over 70 ultra-premium, highly allocated wineries from Sonoma and Napa Regions, curated gourmet food pairings, entertainment, and a charity auction — all in support of life-saving health services for women and children in southern Haiti.   VineyardsInTheValley.org.  

En este episodio, exploramos un fenómeno cada vez más inquietante en las consultas y unidades de neurología: el aumento del ictus en adultos jóvenes. A partir de la evidencia más reciente, analizamos cómo los factores de riesgo clásicos están dando paso a nuevos protagonistas del siglo XXI, entre ellos el estrés crónico. Revisamos el papel del ictus criptogénico, las causas vasculares menos conocidas y los mecanismos por los cuales la sobrecarga emocional, laboral o social puede alterar la fisiología cerebrovascular hasta precipitar un evento agudo. También abordamos la diferencia de impacto entre hombres y mujeres, los hallazgos de estudios internacionales como INTERSTROKE y ERICH, y cómo la gestión del estrés debería considerarse una estrategia real de prevención neurológica. Un episodio para reflexionar sobre la relación entre mente, sociedad y cerebro en una generación que vive —y enferma— bajo presión. Referencias del episodio: 1. Behymer, T. P., Sekar, P., Demel, S. L., Aziz, Y. N., Coleman, E. R., Williamson, B. J., Stanton, R. J., Sawyer, R. P., Turner, A. C., Vagal, V. S., Osborne, J., Gilkerson, L. A., Comeau, M. E., Flaherty, M. L., Langefeld, C. D., & Woo, D. (2025). Psychosocial Stress and Risk for Intracerebral Hemorrhage in the ERICH (Ethnic/Racial Variations of Intracerebral Hemorrhage) Study. Journal of the American Heart Association, 14(6), e024457. https://doi.org/10.1161/JAHA.121.024457 (https://pubmed.ncbi.nlm.nih.gov/40055853/). 2. Egido, J. A., Castillo, O., Roig, B., Sanz, I., Herrero, M. R., Garay, M. T., Garcia, A. M., Fuentes, M., & Fernandez, C. (2012). Is psycho-physical stress a risk factor for stroke? A case-control study. Journal of neurology, neurosurgery, and psychiatry, 83(11), 1104–1110. https://doi.org/10.1136/jnnp-2012-302420 (https://pubmed.ncbi.nlm.nih.gov/22930814/). 3. Gutiérrez-Zúñiga, R., Fuentes, B., & Díez-Tejedor, E. (2018). Ictus criptogénico. Un no diagnóstico. Medicina Clínica, 151 (3), 116-122. https://doi.org/10.1016/j.medcli.2018.01.024 (https://www.sciencedirect.com/science/article/abs/pii/S0025775318300770). 4. Khan, M., Wasay, M., O'Donnell, M. J., Iqbal, R., Langhorne, P., Rosengren, A., Damasceno, A., Oguz, A., Lanas, F., Pogosova, N., Alhussain, F., Oveisgharan, S., Czlonkowska, A., Ryglewicz, D., & Yusuf, S. (2023). Risk Factors for Stroke in the Young (18-45 Years): A Case-Control Analysis of INTERSTROKE Data from 32 Countries. Neuroepidemiology, 57(5), 275–283. https://doi.org/10.1159/000530675 (https://pubmed.ncbi.nlm.nih.gov/37231971/). 5. Kutal, S., Tulkki, L. J., Sarkanen, T., Redfors, P., Jood, K., Nordanstig, A., Yeşilot, N., Sezgin, M., Ylikotila, P., Zedde, M., Junttola, U., Fromm, A., Ryliskiene, K., Licenik, R., Ferdinand, P., Jatužis, D., Kõrv, L., Kõrv, J., Pezzini, A., Sinisalo, J., … Martinez-Majander, N. (2025). Association Between Self-Perceived Stress and Cryptogenic Ischemic Stroke in Young Adults: A Case-Control Study. Neurology, 104(6), e213369. https://doi.org/10.1212/WNL.0000000000213369 (https://pubmed.ncbi.nlm.nih.gov/40043226/). 6. Li, W., Zhang, J., Zhang, Y., Shentu, W., Yan, S., Chen, Q., Qiao, S., & Kong, Q. (2025). Clinical research progress on pathogenesis and treatment of Patent Foramen Ovale-associated stroke. Frontiers in neurology, 16, 1512399. https://doi.org/10.3389/fneur.2025.1512399 (https://pubmed.ncbi.nlm.nih.gov/40291846/). 7. Smyth, A., O'Donnell, M., Hankey, G. J., Rangarajan, S., Lopez-Jaramillo, P., Xavier, D., Zhang, H., Canavan, M., Damasceno, A., Langhorne, P., Avezum, A., Pogosova, N., Oguz, A., Yusuf, S., & INTERSTROKE investigators (2022). Anger or emotional upset and heavy physical exertion as triggers of stroke: the INTERSTROKE study. European heart journal, 43(3), 202–209. https://doi.org/10.1093/eurheartj/ehab738 (https://pubmed.ncbi.nlm.nih.gov/34850877/). 8. Verhoeven, J. I., Fan, B., Broeders, M. J. M., Driessen, C. M. L., Vaartjes, I. C. H., Klijn, C. J. M., & de Leeuw, F. E. (2023). Association of Stroke at Young Age With New Cancer in the Years After Stroke Among Patients in the Netherlands. JAMA network open, 6(3), e235002. https://doi.org/10.1001/jamanetworkopen.2023.5002 (https://pubmed.ncbi.nlm.nih.gov/36976557/). 9. Wegener S. (2022). Triggers of stroke: anger, emotional upset, and heavy physical exertion. New insights from the INTERSTROKE study. European heart journal, 43(3), 210–212. https://doi.org/10.1093/eurheartj/ehab755 (https://pubmed.ncbi.nlm.nih.gov/34850880/). 10. Yaghi, S., Bernstein, R. A., Passman, R., Okin, P. M., & Furie, K. L. (2017). Cryptogenic Stroke: Research and Practice. Circulation research, 120(3), 527–540. https://doi.org/10.1161/CIRCRESAHA.116.308447 (https://pubmed.ncbi.nlm.nih.gov/28154102/). 11. Yang, D., & Elkind, M. S. V. (2023). Current perspectives on the clinical management of cryptogenic stroke. Expert review of neurotherapeutics, 23(3), 213–226. https://doi.org/10.1080/14737175.2023.2192403 (https://pubmed.ncbi.nlm.nih.gov/36934333/).

We're excited to welcome Chrissy Meyer from the American Heart Association, Sioux Falls, and Jessica Crawford, Business + Community Relations Manager, to the Build Blue Podcast!In this episode, we delve into Hard Hats with Heart, a groundbreaking initiative dedicated to enhancing heart health and wellness within the construction industry. From stress and long hours to physical demands on the jobsite, construction workers face unique risks, and Chrissy breaks down how this program is making a real difference.Catch the full conversation here. #BuildBluePodcast #APXConstructionGroup #HardHatsWithHeart #AmericanHeartAssociation #SiouxFallsSD #ConstructionIndustry #HeartHealthAwareness #SafetyFirst #CommunityFirst

Howie and Harlan are joined by Harvard internist Jerry Avorn to discuss his research on the pharmaceutical industry and his work promoting evidence-based prescribing. Harlan highlights new results from the American Heart Association meeting, including a one-time CRISPR-based therapy for high cholesterol; Howie reports on an outbreak of infant botulism. Show notes: Research from the American Heart Association Meeting "Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3" "First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides" "Cardiac Allograft Vasculopathy Inhibition with Alirocumab: The CAVIAR Trial" "PCSK9 medication plus statin may help lower cholesterol after heart transplant" "Investigational daily pill lowered bad cholesterol as much as injectables" Jerry Avorn Science Direct: Academic Detailing Jerry Avorn: "Principles of Educational Outreach ('Academic Detailing') to Improve Clinical Decision Making" Alosa Health FDA: Accelerated Approval Jerry Avorn: Rethinking Medications: Truth, Power, and the Drugs You Take FDA: Direct-to-Consumer (DTC) Advertisements H.R.5952 - Prescription Drug User Fee Act of 1992 FDA: FY 2025 FDA Budget Summary Centers for Medicare & Medicaid Services: Open Payments  H.R.3590 - Patient Protection and Affordable Care Act "Aducanumab Discontinued as an Alzheimer's Treatment" FDA: ELEVIDYS Brigham and Women's Hospital & Harvard Medical School: Division of Pharmacoepidemiology and Pharmacoeconomics Amazon.com: Featured comments on Rethinking Medications Infant Botulism California Department of Public Health: "Outbreak of Infant Botulism Linked to ByHeart Infant Formula" California Department of Public Health: Infant Botulism Treatment and Prevention Program CDC: "Infant Botulism Outbreak Linked to Infant Formula, November 2025" "ByHeart recalls all baby formula sold nationwide as infant botulism outbreak grows" California Department of Public Health: What is BabyBIG? California Department of Public Health: Postponement of BabyBIG Fee Increase California Department Of Public Health: Invoice and Purchase Agreement for BabyBIG In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.  

The American Heart Association's West Valley Heart Walk returns for its third year this Saturday, November 15th. Katelyn McMahan shares the story of her two-year-old, Goldie, and Heart Walk Chair Ruben Castro with Abrazo Health shares his very personal connection to the event.   

Direto do congresso da American Heart Association, em New Orleans, o DozeCast traz o que realmente interessa: os late-breaking trials que podem mexer na sua conduta (ou não) já na próxima semana — com leitura crítica, contexto e aplicabilidade. Mateus Prata, Raphael Rossi e Victor Bemfica apontam o que é sinal e o que é ruído.Como de costume, filtramos o AHA em mensagens práticas, com erros comuns a evitar, possível impacto em guidelines futuras e se há algo que vale adotar agora.Ouça no Spotify ou assista no YouTube — e mande para o colega que quer voltar do congresso já atualizado.Palavras-chave (SEO): AHA, American Heart Association, AHA New Orleans, late-breaking trials, cardiologia, prevenção cardiovascular, insuficiência cardíaca, fibrilação atrial, antitrombóticos, intervenção coronária, imagem cardiovascular, prática clínica. _______________Assine agora! Revisões didáticas de Cardiologia, semanalmente na DozeNews PRIME: a maneira mais leve e rápida de se manter atualizado(a), através do link dozeporoito.com/prime

Howie and Harlan are joined by Harvard internist Jerry Avorn to discuss his research on the pharmaceutical industry and his work promoting evidence-based prescribing. Harlan highlights new results from the American Heart Association meeting, including a one-time CRISPR-based therapy for high cholesterol; Howie reports on an outbreak of infant botulism. Show notes: Research from the American Heart Association Meeting "Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3" "First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides" "Cardiac Allograft Vasculopathy Inhibition with Alirocumab: The CAVIAR Trial" "PCSK9 medication plus statin may help lower cholesterol after heart transplant" "Investigational daily pill lowered bad cholesterol as much as injectables" Jerry Avorn Science Direct: Academic Detailing Jerry Avorn: "Principles of Educational Outreach ('Academic Detailing') to Improve Clinical Decision Making" Alosa Health FDA: Accelerated Approval Jerry Avorn: Rethinking Medications: Truth, Power, and the Drugs You Take FDA: Direct-to-Consumer (DTC) Advertisements H.R.5952 - Prescription Drug User Fee Act of 1992 FDA: FY 2025 FDA Budget Summary Centers for Medicare & Medicaid Services: Open Payments  H.R.3590 - Patient Protection and Affordable Care Act "Aducanumab Discontinued as an Alzheimer's Treatment" FDA: ELEVIDYS Brigham and Women's Hospital & Harvard Medical School: Division of Pharmacoepidemiology and Pharmacoeconomics Amazon.com: Featured comments on Rethinking Medications Infant Botulism California Department of Public Health: "Outbreak of Infant Botulism Linked to ByHeart Infant Formula" California Department of Public Health: Infant Botulism Treatment and Prevention Program CDC: "Infant Botulism Outbreak Linked to Infant Formula, November 2025" "ByHeart recalls all baby formula sold nationwide as infant botulism outbreak grows" California Department of Public Health: What is BabyBIG? California Department of Public Health: Postponement of BabyBIG Fee Increase California Department Of Public Health: Invoice and Purchase Agreement for BabyBIG In the Yale School of Management's MBA for Executives program, you'll get a full MBA education in 22 months while applying new skills to your organization in real time. Yale's Executive Master of Public Health offers a rigorous public health education for working professionals, with the flexibility of evening online classes alongside three on-campus trainings. Email Howie and Harlan comments or questions.  

This week, Dr. Kahn breaks down new research presented at the American Heart Association linking melatonin use to congestive heart failure. Should you be concerned? He shares his expert perspective. Also in this episode: aspirin use in diabetes, fruit's role in Parkinson's disease, how metformin affects exercise results, the impact of heavy metals like mercury on heart health, why daily walking supports "Life's Essential 8" for Alzheimer's prevention, new CCTA data proving the benefits of statins, and how marriage might influence aging.  Don't forget to sample some high-quality olive oil at getfreshdrkahn.com.

Send us a textImportance of Sleep Inactive Sleep Mask https://inactiveco.com/What if the simplest tool in your bedroom could unlock better recovery, steadier mood, and sharper performance? We sit down with Jill McCray—co-founder of the Inactive Company and former executive at Spanx, Starbucks, and Delta—to unpack how a century-old sleep accessory became a serious performance tool for athletes, veterans, parents, and frequent flyers. Jill traces the journey from “I'll sleep when I'm dead” to building a patented sleep mask that delivers complete darkness, active cooling with phase change material, and hardware‑free comfort that fits any head and even lets you open your eyes under the mask—an insight that dramatically increased adoption in PTSD cohorts.We explore why sleep has jumped to the top of the wellness pyramid (hello, American Heart Association's Essential 8), and how elite programs validated the design. From NFLPA reorders and college football travel kits to third‑party studies showing 15–30 minutes more sleep per night, the data points add up. Jill breaks down the four pillars of better sleep—darkness for melatonin signaling, thermoregulation for fewer 3 a.m. wakeups, deeper REM and slow‑wave quality, and comfort that drives real-world compliance. We also dig into their CBT‑I inspired Sleep Seven playbook, a personalizable routine that turns the mask into a reliable cue—your nightly “sleep warm‑up” that helps your body power down and stay there.If you've tried apps, supplements, and gadgets with little payoff, this conversation offers a refreshing, evidence-aware approach to sleep optimization. You'll learn how textile science borrowed from aerospace quietly stabilizes temperature, why design details matter for anxious or trauma-affected sleepers, and where performance sleepwear is headed next with infrared-friendly, cooling fabrics. Ready to treat sleep like a trainable skill and not a lottery? Tune in, try the playbook at inactiveco.com, and tell us your biggest sleep blocker. If this helped, subscribe, share with a friend who needs better nights, and leave a quick review—we read them all and they mean a lot. Support the show Sponsor Affiliates Empowering Your Health https://www.atecam.com/ Get YOUR Own Joburg Protein Snacks Discount Code: Damaris15 Or Damaris18 Feeling need to Lose Weight & Become metabolically Healthy GET METABOLIC COURSE GLP 1 REseT This course is designed for individuals looking to optimize their metabolic health through integrative and functional medicine approaches. Whether you're on a GLP-1 medication or seeking natural ways to enhance your metabolic function, this course provides actionable steps, expert insights, and a personalized roadmap sustainable wellness. Are you feeling stressed, tired, or Metabolism imbalanced? Take advantage of our free mindful steps to help improve your well-being.ENJOY ONE OF our Books Mindful Ways Health Wealth & Life https://stan.store/Mindfullyintegrative Join Yearly membership ALL IN ONE FUNCTION HEALTH Ask Us for help...

In the latest episode of Parallax, Dr Ankur Kalra welcomes Dr Martha Gulati and Dr Anu Lala for a groundbreaking conversation about reimagining heart failure prevention across the entire disease spectrum. Their discussion centres on an innovative scientific statement developed collaboratively between the American Society of Preventive Cardiology and the Heart Failure Society of America - a document that challenges conventional approaches to cardiovascular disease prevention. Dr Gulati and Dr Lala make a compelling case for expanding prevention beyond atherosclerotic cardiovascular disease (ASCVD) to encompass heart failure, a condition affecting one in four individuals over their lifetime. They introduce the American Heart Association's Cardio Kidney Metabolic (CKM) health framework as a superior model for identifying at-risk patients, explaining how this approach shifts focus from disease management to health optimization. The conversation explores practical implementation strategies, including the new PREVENT risk score, which integrates critical heart failure risk factors like obesity and chronic kidney disease that traditional assessment tools overlook. Questions and comments can be sent to "podcast@radcliffe-group.com" and may be answered by Ankur in the next episode. Host: @AnkurKalraMD and produced by: @RadcliffeCardio Parallax is Ranked in the Top 100 Health Science Podcasts (#48) by Million Podcasts.

Send us a textDr. Koren joins Kevin Geddings to report live from the American Heart Association meeting in New Orleans with fresh results on LDL lowering, prevention, and the future of gene editing for cholesterol. They discuss the excitement of big meetings like the AHA and how results can even surprise the investigators that were working on a study.Note: Dr. Koren refers to CRISPR Therapeutics, a company developing gene-based cholesterol lowering technologies. CRISPR-Cas9 is also the general name of a gene editing technique.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Women and Stroke: Recovery, Prevention and Health Equity In this episode of "Stronger After Stroke," host Rosa Hart, BSN, R.N., SCRN, talks with Tamika Burrus, M.D., a stroke neurology specialist, about how stroke uniquely affects women. Together, they explore critical differences in how women respond to stroke treatments, such as thrombolytics (alteplase and tenecteplase) and mechanical thrombectomy, why recovery can look different for women, and what steps health care systems can take to close the gender gap in stroke outcomes. Dr. Burrus shares insights on physical, cognitive and emotional recovery challenges that women often face after stroke. The conversation also highlights disparities in stroke rehabilitation access, follow-up care and stroke prevention — particularly among Black and Hispanic women, who face a higher risk. Listeners will gain practical takeaways on how women can reduce their stroke risk through lifestyle changes, the importance of early screening by primary care and OB/GYN providers, and how health care professionals can improve outcomes through education, advocacy and equitable care. In this episode, you will learn: How estrogen impacts the cardiovascular system The unique physical, cognitive and emotional recovery challenges women face after stroke Disparities in access to rehabilitation and follow-up care for women compared with men Lifestyle changes that can significantly reduce stroke risk for women at any age How racial and ethnic disparities affect stroke risk among Black and Hispanic women The role of primary care and OB/GYN providers in early stroke risk screening Common misconceptions about stroke in women The most important next steps for women recovering from stroke How nurses and health care professionals can improve stroke outcomes and equity Key takeaway:Women experience stroke differently — biologically, socially and systemically. Improving prevention, early detection and equitable access to care can help save lives and support stronger recoveries. About our guest:Tamika M. Burrus, M.D., is a stroke neurologist with Norton Neuroscience Institute. Dr. Burrus earned her medical degree from the University of Iowa in Iowa City. She completed her residency in neurology at the Mayo Clinic in Rochester, Minnesota, and a fellowship in vascular neurology at the University of California, San Francisco. She is a fellow of the American Academy of Neurology and co-author on several national guidelines for the American Academy of Neurology and the American Heart Association. Dr. Burrus believes it is important to ensure that patients feel as if their interaction is a partnership. She strives to help her patients understand their brain and spine and to collaborate with her regarding the best treatment plan for them. She has specialized expertise in telemedicine and was one of the early adopters in the field of teleneurology. Dr. Burrus is a Louisville native. In her spare time, she enjoys traveling and has visited 44 U.S. states and numerous countries outside North America. Dr. Burrus also likes cooking, art and philanthropic endeavors.   Want more inspiring stories and real-life resources? Subscribe and share "Stronger After Stroke" with someone who needs a little extra support navigating life after stroke. For more support after stroke, check out the programs available online and in person through  Norton Neuroscience Institute Resource Centers: https://nortonhealthcare.com/services-and-conditions/neurosciences/patient-resources/resource-center/ If you enjoyed this podcast, listen to Norton Healthcare's "MedChat" podcast, available in your favorite podcast app. "MedChat" provides continuing medical education on the go and is targeted toward physicians and clinicians. Norton Healthcare, a not-for-profit health care system, is a leader in serving adult and pediatric patients throughout Greater Louisville, Southern Indiana, the commonwealth of Kentucky and beyond. A strong research program provides access to clinical trials in a multitude of areas. More information about Norton Healthcare is available at NortonHealthcare.com.   Date of original release: Nov. 10, 2025

On this episode of West Virginia Outdoors, Chirs talks with Holly Mitchell from the American Heart Association on their Heart Healthy Hunting campaign, and Steve Rauch from the West Virginia DNR on this year's white-tailed deer rutting season.

Upgrade your biology in 10 minutes with this week's rundown from Dave Asprey. This episode breaks down the six biggest stories in biohacking and health tech, from sleep hormones to mitochondrial rejuvenation, giving you the data you need to live longer, think faster, and perform at your peak. This episode covers: • The Melatonin Heart Warning Everyone Missed A major new study from the American Heart Association reveals that long-term melatonin users face nearly twice the risk of heart failure and 3.5 times higher hospitalization rates. Once considered a harmless sleep aid, melatonin's hormonal effects may disrupt cardiovascular recovery, testosterone, and blood pressure regulation when used nightly. The takeaway: melatonin is a short-term circadian reset tool, not a forever supplement. Source: American Heart Association — newsroom.heart.org/news/long-term-use-of-melatonin-supplements-to-support-sleep-may-have-negative-health-effects • Bryan Johnson's Extreme Microplastics Detox Biohacker Bryan Johnson shared lab-verified results showing an 85% reduction in microplastics in his semen after one year of daily 200°F dry saunas followed by ice packs on the groin. It's not peer reviewed yet, but it'ssparking global discussion about environmental toxins, fertility, and detoxification. Whether or not you follow his protocol, this study highlights how widespread microplastics have become and how heat, sweat, and smarter exposure control may help fight back. Source: New York Post — nypost.com/2025/10/23/health/biohacker-bryan-johnson-got-rid-of-85-of-microplastics-from-his-semen • Urolithin A: The Mitochondrial Molecule That Strengthens Immunity A peer-reviewed human trial published in Nature Aging found that four weeks of daily Urolithin A (Mitopure®) supplementation improved immune function in adults aged 45–70, increasing youthful CD8 T-cells, natural killer cells, and mitochondrial performance inside immune cells. By triggering mitophagy, your body's cleanup process for old mitochondria, Urolithin A enhances energy, resilience, and immune strength. It's the clearest evidence yet that we can modulate immune aging through mitochondrial renewal. Head to timeline.com/dave to get 10% off your first order. Source: BioSpace — biospace.com/press-releases/timeline-continues-to-build-the-most-clinically-researched-longevity-products-targeting-immune-brain-and-muscle-aging • Google's New AI Model That “Talks” to Cells Google DeepMind and Yale launched Cell2Sentence-Scale, an open-source AI model that lets scientists query cellular pathways in natural language. The system can predict how cells transition from healthy to cancerous states and identify molecular switches that might reverse those changes. It's compressing years of biology into days and democratizing research for small labs and independent scientists alike. Isn't AI a beautiful thing? Source: Google DeepMind — blog.google/technology/ai/google-gemma-ai-cancer-therapy-discovery • Omega-3s Calm the Brain and the Temper A massive new meta-analysis of randomized controlled trials shows omega-3 fatty acids (EPA and DHA) reduce aggression by up to 28%. That includes both reactive anger and planned aggression. By lowering neuroinflammation and stabilizing cell membranes, omega-3s appear to balance dopamine and serotonin, proving that healthy fats aren't just heart food, they're emotional regulators too. Source: Science Alert — sciencealert.com/one-dietary-supplement-was-shown-to-reduce-aggression-by-up-to-28 • Chronic Fatigue Syndrome Finally Gets a Biomarker For the first time, researchers have developed a blood test that accurately identifies chronic fatigue syndrome (ME/CFS) using DNA methylation and micro-RNA expression patterns. This breakthrough distinguishes CFS from other autoimmune and viral conditions, marking a turning point for millions of patients long dismissed by traditional medicine. It's proof that data-driven diagnostics can transform how we understand mystery illnesses. Source: Science Daily — sciencedaily.com/releases/2025/11/251102205021.htm All source links provided for easy reference to the original reporting and research above. This is essential listening for fans of biohacking, hacking human performance, functional medicine, and longevity who want actionable tools from Host Dave Asprey and a guest who embodies what it means to age with energy, clarity, and vitality. Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade brings you the knowledge to take control of your biology, extend your longevity, and optimize every system in your body and mind. Each episode delivers cutting-edge insights in health, performance, neuroscience, supplements, nutrition, biohacking, emotional intelligence, and conscious living. New episodes are released every Tuesday, Thursday, Friday, and Sunday (BONUS). Dave asks the questions no one else will and gives you real tools to become stronger, smarter, and more resilient. Keywords: melatonin heart risk, sleep hormones, microplastics detox, Bryan Johnson, Urolithin A, mitophagy, mitochondrial health, immune aging, DeepMind AI, cellular modeling, omega-3 aggression, neuroinflammation, chronic fatigue biomarker, ME/CFS test, biohacking news, longevity research Thank you to our sponsors! -LYMA | Go to https://lyma.sjv.io/gOQ545 and use code DAVE10 for 10% off the LYMA Laser.-Vibrant Blue Oils | Grab a full-size bottle for over 50% off at https://vibrantblueoils.com/dave. Resources: • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Upgrade Collective: https://www.ourupgradecollective.com • Upgrade Labs: https://upgradelabs.com • 40 Years of Zen: https://40yearsofzen.com Timestamps: 0:00 — Intro 0:18 — Story 1: Melatonin & Heart Health 1:58 — Story 2: Microplastics Detox 3:39 — Story 3: Urolithin A & Immune Function 5:19 — Story 4: AI Cell Model 6:57 — Story 5: Omega-3 & Aggression 8:43 — Story 6: CFS Blood Test 9:59 — Weekly Upgrade Protocol See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Filmed live before a studio audience, Del Bigtree and Jefferey Jaxen break down Bill Gates' shocking reversal on climate change — signaling that the global narrative may finally be unraveling. Then, a new American Heart Association study reveals alarming data on the COVID vaccine's impact on the heart — a discovery that could mark the final blow for mRNA technology. Plus, an unprecedented in-studio panel brings together Dr. Andrew Wakefield, Dr. Pierre Kory, and Dr. Suzanne Humphries — three medical truth-tellers confronting the biggest questions of our time: Are we witnessing the collapse of a system built on misinformation? Or the rebirth of true science and transparency?Watch this powerful new episode of The HighWire, where the truth always comes straight from the heart.Guests: Dr. Suzanne Humphries, Dr. Pierre Kory, Dr. Andrew WakefieldBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

Featuring Brad Pritchett, Chief Experience Officer at the Dallas Museum of ArtIf there's one person redefining how Dallas connects with culture, it's Brad Pritchett. As the Chief Experience Officer at the Dallas Museum of Art, Brad isn't just curating exhibits; he's curating connection. With his trademark blend of creativity, candor, and charm, he's turning one of the city's most storied institutions into a living, breathing experience that invites everyone in.His path here wasn't exactly linear, and that's part of what makes it brilliant. From growing up in a Southern Baptist home to performing on cruise ships, from television correspondent to community advocate, Brad's story is about becoming who you really are, even when that means rewriting your own script.In this episode of Counsel Brew, Brad opens up about authenticity, transformation, and finding joy in the work that moves you. He shares what it means to lead with empathy and imagination, and how art can be both a mirror and a megaphone for community. We talk about Dallas' thriving arts scene, his passion for making the DMA accessible to everyone, and yes, his unapologetic love for fall décor and a perfectly crafted pecan cortado.Brad reminds us that art isn't confined to galleries; it's found in the stories we tell, the spaces we create, and the courage it takes to live out loud.So pour your brew (bonus points if has a hint of Fall flavor) and join us for a conversation with the man who Dreams it, Makes it, and Amplifies it, one bold, beautiful idea at a time.

The American Heart Association has new guidance on choking response for infants, children and adults, and for treating individuals with suspected opioid overdose.

Claire de Mézerville López welcomes Erica Vogel, CEO of Community Matters, to the Restorative Works! Podcast for this special series titled Matters that Restore Community in partnership with Community Matters. Community Matters is an internationally recognized, innovative, and thought-leading organization committed to improving the social-emotional climate of schools and communities. Founded in 1996, Community Matters has evolved from its roots in youth development and bullying prevention to become a respected provider of training, consulting, and programs delivered through its whole school climate framework. Community Matters has empowered more than 170,000 students and served over 2,100 schools across 42 states, the District of Columbia, as well as Guam, Paraguay, Japan, Puerto Rico, and Canada. Erica reflects on decades of youth empowerment work, sharing moving stories that show how small acts of courage ripple across entire communities. From a student in Wyoming who used humor to defuse a fight, shouting "I love rainbows and unicorns!" to Erica's own son, whose quiet leadership as a Safe School Ambassador shaped his path toward a career in mental health, these moments illustrate the heart of restorative practices culture: connection, belonging, and empowerment. Erica is the CEO of Community Matters whose mission is to engage, equip and empower youth and adults to create schools and communities that are safe, welcoming and inclusive for all. Erica has extensive experience in youth development and programming with a specialization in developing and implementing youth empowerment programs for disadvantaged and culturally diverse young people. Erica has over 25 years of experience in the non-profit management, education, and youth development field, holding executive and senior level positions with Big Brothers Big Sisters, the American Heart Association, and the YMCA prior to joining Community Matters in 2010. She holds a Bachelor of Arts in Management and Organizational Development from Spring Arbor University (Michigan).  Tune in to explore how shifting adult mindsets, fostering youth-adult partnerships, and supporting students year-round cultivates not just safety, but deep, lasting community. After the interview with Erica, stay tuned to hear from Safe School Ambassador Elli who shared more about her experience as a student leading her community.

Things can get hectic during AEP. From sales appointments, applications, and following up with clients, it's easy to brush aside rest and self-care, so consider this episode as a reminder!   Read the text version   Save Time, Sell More - IntegrityCONNECT   Contact the Agent Survival Guide Podcast! Email us ASGPodcast@Ritterim.com or call 1-717-562-7211 and leave a voicemail.   Resources: A Review of Integrity's Top Medicare Quoting Tools Agent Survival Kits Do's and Don'ts of Medicare Compliance How Ask Integrity Can Streamline Your Medicare Sales Appointments IntegrityCONNECT - Login PlanEnroll – Take Your Business to the Next Level Ritter's Round Table Your Guide to Forming an Insurance Agent Network   Fun Local Resources near Harrisburg PA: Lancatster Cat Cafe Meditation to Calm the Mind (Free) Round-A-Bout-Bagels Carlisle Cat Cafe Volunteer with The Harrisburg Humane Society (Free) Wildwood Park (Free) – Harrisburg PA Yoga at Harrisburg YMCA   References: “3 Tips to Manage Stress.” Www.Heart.Org, American Heart Association, https://www.heart.org/en/healthy-living/healthy-lifestyle/stress-management/3-tips-to-manage-stress. Accessed 8 Oct. 2025. “Your Frontline Source for Tech News.” Techreport, 6 Oct. 2025, https://techreport.com/. Mayo Clinic Staff. “Stress Relievers: Tips to Tame Stress.” Mayo Clinic, Mayo Foundation for Medical Education and Research, 3 Aug. 2023, https://www.mayoclinic.org/healthy-lifestyle/stress-management/in-depth/stress-relievers/art-20047257. Matijczak, Angela, et al. “The Influence of Interactions With Pet Dogs on Psychological Distress.” American Psychological Association, American Psychological Association, https://psycnet.apa.org/fulltext/2023-97081-001.html. Accessed 8 Oct. 2025.   Follow Us on Social! Ritter on Facebook, https://www.facebook.com/RitterIM Instagram, https://www.instagram.com/ritter.insurance.marketing/ LinkedIn, https://www.linkedin.com/company/ritter-insurance-marketing TikTok, https://www.tiktok.com/@ritterim X, https://x.com/RitterIM and YouTube, https://www.youtube.com/user/RitterInsurance     Sarah on LinkedIn, https://www.linkedin.com/in/sjrueppel/ Instagram, https://www.instagram.com/thesarahjrueppel/ and Threads, https://www.threads.net/@thesarahjrueppel  Tina on LinkedIn, https://www.linkedin.com/in/tina-lamoreux-6384b7199/   Not affiliated with or endorsed by Medicare or any government agency.

Dr Sharonne Hayes, Professor of cardiovascular medicine and founding director of Mayo Clinic women's heart clinic, and Dr. Marysia Tweet, Associate Professor of cardiovascular medicine, and co-leader of the Spontaneous Coronary Artery Dissection Registry and leader in women's heart health join the show for this amazing November chapter of Always on EM. They are world experts on Spontaneous Coronary Artery Dissection authoring over 60 peer reviewed articles on the topic and in this chapter we explore with them the pitfalls and pearls related to making this diagnosis in the ED. SCAD is an important cause of myocardial infarction especially in patients who would not otherwise seem to be at risk for heart attacks for example active young women without comorbidities, and its imperitive that we as emergency physicians are current on this diagnosis.   DONATE TO DR JIM GREGOIRE SCHOLARSHIP FUND To honor the life of Dr. Jim Gregoire, dear friend of this show, consider donating to his scholarship fund. Go to https://give.mayoclinic.org/give/616870/#!/donation/checkout Go to: What would you like your donation to support? Choose “other” Enter: James Gregoire Scholarship Fund   CONTACTS X - @AlwaysOnEM; @VenkBellamkonda; @Marysia_Tweet; @SharonneHayes YouTube - @AlwaysOnEM; @VenkBellamkonda Instagram – @AlwaysOnEM; @Venk_like_vancomycin; @ASFinch; @SharonneHayes Email - AlwaysOnEM@gmail.com   DO YOU HAVE SCAD? DOES YOUR PATIENT HAVE SCAD? WANT TO GET CONNECTED? SCAD Research: www.scadresearch.org National Coalition for Women with Heart Disease: www.womenheart.org Mayo Clinic Womens Heart clinic: https://www.mayoclinic.org/departments-centers/womens-heart-clinic/overview/ovc-20442061   REFERENCES & LINKS Saleh G, Al-Abcha A, Chaaban K, Adi MZ, Tweet M, Collins JD, Alkhouli M, Gulati R. Concomitant Takotsubo Cardiomyopathy and Spontaneous Coronary Artery Dissection: Exploring the Role of Cardiac Mechanics on Coronary Disruption. JACC Cardiovasc Imaging. 2025 Oct;18(10):1161-1166. doi: 10.1016/j.jcmg.2025.05.020. Epub 2025 Aug 5. PMID: 40758075. Baqal O, Karikalan SA, Hasabo EA, Tareen H, Futela P, Qasba RK, Shafqat A, Qasba RK, Hayes SN, Tweet MS, El Masry HZ, Lee KS, Shen WK, Sorajja D. In- hospital and long-term outcomes in spontaneous coronary artery dissection with concurrent cardiac arrest: Systematic review and meta-analysis. Heart Rhythm O2. 2025 Apr 24;6(6):843-853. doi: 10.1016/j.hroo.2025.03.023. PMID: 40717849; PMCID: PMC12287955. Morosato M, Gaspardone C, Romagnolo D, Pagnesi M, Baldetti L, Dormio S, Federico F, Scandroglio AM, Chieffo A, Godino C, Margonato A, Adamo M, Metra M, Tchetche D, Dumonteil N, Tweet MS, Saw J, Beneduce A. Left Main Spontaneous Coronary Artery Dissection: Clinical Features, Management, and Outcomes. JACC Cardiovasc Interv. 2025 Apr 28;18(8):975-983. doi: 10.1016/j.jcin.2025.01.427. Epub 2025 Apr 9. PMID: 40208153; PMCID: PMC12290918. Tweet MS, Pellikka PA, Gulati R, Gochanour BR, Barrett-O'Keefe Z, Raphael CE, Best PJM, Hayes SN. Coronary Artery Tortuosity and Spontaneous Coronary Artery Dissection: Association With Echocardiography and Global Longitudinal Strain, Fibromuscular Dysplasia, and Outcomes. J Am Soc Echocardiogr. 2024 May;37(5):518-529. doi: 10.1016/j.echo.2024.02.013. Epub 2024 Mar 11. PMID: 38467311; PMCID: PMC11605948. Tweet MS, Hayes SN, Grimaldo ABG, Rose CH. Pregnancy After Spontaneous Coronary Artery Dissection: Counseling Patients Who Intend Future Pregnancy. JACC Adv. 2023 Dec;2(10):100714. doi: 10.1016/j.jacadv.2023.100714. Epub 2023 Nov 14. PMID: 38915307; PMCID: PMC11194843. Tarabochia AD, Tan NY, Lewis BR, Slusser JP, Hayes SN, Best PJM, Gulati R, Deshmukh AJ, Tweet MS. Association of Spontaneous Coronary Artery Dissection With Atrial Arrhythmias. Am J Cardiol. 2023 Jan 1;186:203-208. doi: 10.1016/j.amjcard.2022.09.032. Epub 2022 Oct 31. PMID: 36328832; PMCID: PMC10403149. Murugiah K, Chen L, Dreyer RP, Bouras G, Safdar B, Lu Y, Spatz ES, Gupta A, Khera R, Ng VG, Bueno H, Tweet MS, Spertus JA, Hayes SN, Lansky A, Krumholz HM. Depression and Perceived Stress After Spontaneous Coronary Artery Dissection and Comparison With Other Acute Myocardial Infarction (the VIRGO Experience). Am J Cardiol. 2022 Jun 15;173:33-38. doi: 10.1016/j.amjcard.2022.03.005. Epub 2022 Mar 29. PMID: 35365290; PMCID: PMC9133198. Johnson AK, Tweet MS, Rouleau SG, Sadosty AT, Hayes SN, Raukar NP. The presentation of spontaneous coronary artery dissection in the emergency department: Signs and symptoms in an unsuspecting population. Acad Emerg Med. 2022 Apr;29(4):423-428. doi: 10.1111/acem.14426. Epub 2021 Dec 26. PMID: 34897898; PMCID: PMC10403148. Murugiah K, Chen L, Dreyer RP, Bouras G, Safdar B, Khera R, Lu Y, Spatz ES, Ng VG, Gupta A, Bueno H, Tweet MS, Spertus JA, Hayes SN, Lansky A, Krumholz HM. Health status outcomes after spontaneous coronary artery dissection and comparison with other acute myocardial infarction: The VIRGO experience. PLoS One. 2022 Mar 23;17(3):e0265624. doi: 10.1371/journal.pone.0265624. PMID: 35320296; PMCID: PMC8942215. Adlam D, Tweet MS, Gulati R, Kotecha D, Rao P, Moss AJ, Hayes SN. Spontaneous Coronary Artery Dissection: Pitfalls of Angiographic Diagnosis and an Approach to Ambiguous Cases. JACC Cardiovasc Interv. 2021 Aug 23;14(16):1743-1756. doi: 10.1016/j.jcin.2021.06.027. PMID: 34412792; PMCID: PMC8383825. Kok SN, Tweet MS. Recurrent spontaneous coronary artery dissection. Expert Rev Cardiovasc Ther. 2021 Mar;19(3):201-210. doi: 10.1080/14779072.2021.1877538. Epub 2021 Feb 26. PMID: 33455483. Campbell KH, Tweet MS. Coronary Disease in Pregnancy: Myocardial Infarction and Spontaneous Coronary Artery Dissection. Clin Obstet Gynecol. 2020 Dec;63(4):852-867. doi: 10.1097/GRF.0000000000000558. PMID: 32701519; PMCID: PMC10767871. Tweet MS, Young KA, Best PJM, Hyun M, Gulati R, Rose CH, Hayes SN. Association of Pregnancy With Recurrence of Spontaneous Coronary Artery Dissection Among Women With Prior Coronary Artery Dissection. JAMA Netw Open. 2020 Sep 1;3(9):e2018170. doi: 10.1001/jamanetworkopen.2020. PMID: 32965500; PMCID: PMC7512056. Hayes SN, Tweet MS, Adlam D, Kim ESH, Gulati R, Price JE, Rose CH. Spontaneous Coronary Artery Dissection: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Aug 25;76(8):961-984. doi: 10.1016/j.jacc.2020.05.084. PMID: 32819471. Johnson AK, Hayes SN, Sawchuk C, Johnson MP, Best PJ, Gulati R, Tweet MS. Analysis of Posttraumatic Stress Disorder, Depression, Anxiety, and Resiliency Within the Unique Population of Spontaneous Coronary Artery Dissection Survivors. J Am Heart Assoc. 2020 May 5;9(9):e014372. doi: 10.1161/JAHA.119.014372. Epub 2020 Apr 28. PMID: 32342736; PMCID: PMC7428589. Tweet MS, Akhtar NJ, Hayes SN, Best PJ, Gulati R, Araoz PA. Spontaneous coronary artery dissection: Acute findings on coronary computed tomography angiography. Eur Heart J Acute Cardiovasc Care. 2019 Aug;8(5):467-475. doi: 10.1177/2048872617753799. Epub 2018 Jan 29. PMID: 29376398; PMCID: PMC6027604. Tan NY, Tweet MS. Spontaneous coronary artery dissection: etiology and recurrence. Expert Rev Cardiovasc Ther. 2019 Jul;17(7):497-510. doi: 10.1080/14779072.2019.1635011. Epub 2019 Jul 5. PMID: 31232618. Waterbury TM, Tweet MS, Hayes SN, Eleid MF, Bell MR, Lerman A, Singh M, Best PJM, Lewis BR, Rihal CS, Gersh BJ, Gulati R. Early Natural History of Spontaneous Coronary Artery Dissection. Circ Cardiovasc Interv. 2018 Sep;11(9):e006772. doi: 10.1161/CIRCINTERVENTIONS.118. PMID: 30354594. Hayes SN, Kim ESH, Saw J, Adlam D, Arslanian-Engoren C, Economy KE, Ganesh SK, Gulati R, Lindsay ME, Mieres JH, Naderi S, Shah S, Thaler DE, Tweet MS, Wood MJ; American Heart Association Council on Peripheral Vascular Disease; Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Genomic and Precision Medicine; and Stroke Council. Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association. Circulation. 2018 May 8;137(19):e523-e557. doi: 10.1161/CIR.0000000000000564. Epub 2018 Feb 22. PMID: 29472380; PMCID: PMC5957087. Tweet MS, Kok SN, Hayes SN. Spontaneous coronary artery dissection in women: What is known and what is yet to be understood. Clin Cardiol. 2018 Feb;41(2):203-210. doi: 10.1002/clc.22909. Epub 2018 Mar 1. PMID: 29493808; PMCID: PMC5953427. Tweet MS, Codsi E, Best PJM, Gulati R, Rose CH, Hayes SN. Menstrual Chest Pain in Women With History of Spontaneous Coronary Artery Dissection. J Am Coll Cardiol. 2017 Oct 31;70(18):2308-2309. doi: 10.1016/j.jacc.2017.08.071. PMID: 29073960; PMCID: PMC5957076. Lindor RA, Tweet MS, Goyal KA, Lohse CM, Gulati R, Hayes SN, Sadosty AT. Emergency Department Presentation of Patients with Spontaneous Coronary Artery Dissection. J Emerg Med. 2017 Mar;52(3):286-291. doi: 10.1016/j.jemermed.2016.09. Epub 2016 Oct 8. PMID: 27727035. Tweet MS, Gulati R, Williamson EE, Vrtiska TJ, Hayes SN. Multimodality Imaging for Spontaneous Coronary Artery Dissection in Women. JACC Cardiovasc Imaging. 2016 Apr;9(4):436-50. doi: 10.1016/j.jcmg.2016.01.009. PMID: 27056163. Tweet MS, Gulati R, Hayes SN. What Clinicians Should Know Αbout Spontaneous Coronary Artery Dissection. Mayo Clin Proc. 2015 Aug;90(8):1125-30. doi: 10.1016/j.mayocp.2015.05.010. PMID: 26250728. Prasad M, Tweet MS, Hayes SN, Leng S, Liang JJ, Eleid MF, Gulati R, Vrtiska TJ. Prevalence of extracoronary vascular abnormalities and fibromuscular dysplasia in patients with spontaneous coronary artery dissection. Am J Cardiol. 2015 Jun 15;115(12):1672-7. doi: 10.1016/j.amjcard.2015.03.011. Epub 2015 Mar 23. PMID: 25929580. Goel K, Tweet M, Olson TM, Maleszewski JJ, Gulati R, Hayes SN. Familial spontaneous coronary artery dissection: evidence for genetic susceptibility. JAMA Intern Med. 2015 May;175(5):821-6. doi: 10.1001/jamainternmed.2014. PMID: 25798899. Liang JJ, Prasad M, Tweet MS, Hayes SN, Gulati R, Breen JF, Leng S, Vrtiska TJ. A novel application of CT angiography to detect extracoronary vascular abnormalities in patients with spontaneous coronary artery dissection. J Cardiovasc Comput Tomogr. 2014 May-Jun;8(3):189-97. doi: 10.1016/j.jcct.2014.02.001. Epub 2014 Apr 4. PMID: 24939067. Tweet MS, Hayes SN, Pitta SR, Simari RD, Lerman A, Lennon RJ, Gersh BJ, Khambatta S, Best PJ, Rihal CS, Gulati R. Clinical features, management, and prognosis of spontaneous coronary artery dissection. Circulation. 2012 Jul 31;126(5):579-88. doi: 10.1161/CIRCULATIONAHA.112. Epub 2012 Jul 16. PMID: 22800851. Tweet MS, Gulati R, Aase LA, Hayes SN. Spontaneous coronary artery dissection: a disease-specific, social networking community-initiated study. Mayo Clin Proc. 2011 Sep;86(9):845-50. doi: 10.4065/mcp.2011.0312. PMID: 21878595; PMCID: PMC3257995.   WANT TO WORK AT MAYO? EM Physicians: https://jobs.mayoclinic.org/emergencymedicine EM NP PAs: https://jobs.mayoclinic.org/em-nppa-jobs   Nursing/Techs/PAC: https://jobs.mayoclinic.org/Nursing-Emergency-Medicine EMTs/Paramedics: https://jobs.mayoclinic.org/ambulanceservice All groups above combined into one link: https://jobs.mayoclinic.org/EM-Jobs

Last week was the Menopause Society meeting in Orlando, and while I couldn't attend in person due to getting sick, I spent the weekend watching all the sessions remotely from bed. What struck me most were the cardiovascular sessions. Recording this on the eve of my mother's one-year death anniversary from a massive heart attack, I want to talk about the real changes that happen when estrogen leaves the chat and why cardiovascular disease awareness among women has actually dropped from 65% to 44% in recent years.I talk through the key cardiovascular takeaways including why white coat hypertension isn't benign, how the 2025 American Heart Association guidelines changed what's considered normal blood pressure, and why perimenopause is a time of accelerated cardiovascular risk when cholesterol and blood pressure can spike suddenly. The most fascinating session covered invisible heart disease: INOCA (ischemia with no obstructive coronary arteries) and microvascular dysfunction. This is when women have chest pain, get full cardiac workups showing wide-open arteries, yet still have reduced blood flow to the heart through tiny vessels that don't show up on standard angiograms.I discuss mental stress ischemia, a hidden killer where emotional stress causes measurable damage and reduced perfusion to the heart even when exercise stress tests are normal. How many women were told they had panic attacks when they actually had coronary microvascular dysfunction? The mind-heart connection is real, and the sympathetic nervous system surge during high stress can constrict small vessels cutting off microcirculation. I share practical steps including finding preventative cardiologists, getting CT angiograms if you have family history, understanding your blood pressure parameters, and why stress reduction isn't just self-care, it's cardiovascular medicine.Highlights:Why awareness that heart disease is the #1 killer in women dropped from 65% to 44%.How white coat hypertension is NOT benign and leads to cardiovascular events.New 2025 blood pressure guidelines: normal is now less than 120/80.Why perimenopause causes accelerated cardiovascular risk with sudden cholesterol spikes.What INOCA and microvascular dysfunction mean for women with chest pain and normal angiograms.How mental stress ischemia causes measurable heart damage even with normal stress tests.If this episode helped you understand cardiovascular risks in menopause and why symptoms like chest pain deserve thorough evaluation beyond standard testing, please share it with women who need this information. Subscribe and leave a review to help more people discover these critical discussions about heart health in midlife.Resources: Microvascular NetworkINOCA Get in Touch with Me: WebsiteInstagramYoutubeSubstack

With Sotiria Liori, Attikon University Hospital, National and Kapodistrian University of Athens - Greece and Julie De Backer, Ghent University Hospital - Belgium. In this episode, Sotiria Liori and Julie De Backer discuss heart failure in adult congenital heart disease patients — covering how congenital lesions and prior repairs shape epidemiology and mechanisms (ventricular remodeling, valvular and conduit dysfunction, arrhythmias), as well as clinical assessment with imaging, biomarkers, and hemodynamics. They outline management with guideline-directed therapy, rhythm considerations, indications for advanced therapies (MCS and transplant), and pregnancy counseling. The episode also highlights multidisciplinary care models and key evidence gaps. Proposed reading:  General Principles of Heart Failure Management in Adult Congenital Heart Disease. Tompkins R, Romfh A. Heart Failure Reviews. 2020;25(4):555-567. doi:10.1007/s10741-019-09895-x Chronic Heart Failure in Congenital Heart Disease: A Scientific Statement From the American Heart Association. Stout KK, Broberg CS, Book WM, et al. Circulation. 2016;133(8):770-801. doi:10.1161/CIR.0000000000000352. Relation Between New York Heart Association Functional Class and Objective Measures of Cardiopulmonary Exercise in Adults With Congenital Heart Disease. Das BB, Young ML, Niu J, et al. The American Journal of Cardiology. 2019;123(11):1868-1873. doi:10.1016/j.amjcard.2019.02.053.  Heart Failure and Patient-Reported Outcomes in Adults With Congenital Heart Disease from 15 Countries. Lu CW, Wang JK, Yang HL, Kovacs AH, et al; APPROACH‐IS consortium, the International Society for Adult Congenital Heart Disease (ISACHD) *.J Am Heart Assoc. 2022 May 3;11(9):e024993. doi: 10.1161/JAHA.121.024993. Epub 2022 Apr 26. Pharmacological Therapy in Adult Congenital Heart Disease: Growing Need, Yet Limited Evidence. Brida M, Diller GP, Nashat H, et al. European Heart Journal. 2019;40(13):1049-1056. doi:10.1093/eurheartj/ehy480. Advanced Heart Failure Therapies For Adults With Congenital Heart Disease: JACC State-of-the-Art Review. Givertz MM, DeFilippis EM, Landzberg MJ, et al. Journal of the American College of Cardiology. 2019;74(18):2295-2312.doi:10.1016/j.jacc.2019.09.004. A Review of Heart Transplantation for Adults With Congenital Heart Disease. McMahon A, McNamara J, Griffin M. Journal of Cardiothoracic and Vascular Anesthesia. 2021;35(3):752-762. doi:10.1053/j.jvca.2020.07.027. Heart Failure in Adult Congenital Heart Disease: From Advanced Therapies to End-of-Life Care. Crossland DS, Van De Bruaene A, Silversides CK, Hickey EJ, Roche SL. The Canadian Journal of Cardiology. 2019;35(12):1723-1739. doi:10.1016/j.cjca.2019.07.626. This 2025 HFA Cardio Talk podcast series is supported by Bayer AG in the form of an unrestricted financial support. The discussion has not been influenced in any way by its sponsor. 

Puedes leer el blogpost completo en www.ecctrainings.com. 1. ¿Por qué estas guías son importantes? Representan la evolución más reciente en el manejo del paro cardíaco. Se enfocan en algo más allá del algoritmo: tecnología, calidad, equipo, y formación. ECCtrainings te entrena no solo en el "qué hacer", sino en el "cómo hacerlo mejor". 2. Avances clave:

Drs Harrington, Rodriguez, and Ridker discuss the changing field of cardiac prevention, where imaging fits in, and the new concept of standard modifiable risk factor-less patients. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association https://doi.org/10.1161/CIR.0000000000001078 Development and Validation of the American Heart Association's PREVENT Equations https://doi.org/10.1161/CIRCULATIONAHA.123.067626 C-Reactive Protein and Cardiovascular Risk Among Women With No Standard Modifiable Risk Factors: Evaluating the 'Smurf-Less but Inflamed' https://doi.org/10.1093/eurheartj/ehaf658 Mortality in STEMI Patients Without Standard Modifiable Risk Factors: A Sex-Disaggregated Analysis of SWEDEHEART Registry Data https://doi.org/10.1016/S0140-6736(21)00272-5 Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women https://www.nejm.org/doi/10.1056/NEJMoa2405182 Statins for the 'SMuRFLess But Inflamed': Silent Vascular Inflammation and the Challenge of Translational Science https://doi.org/10.1016/j.jacbts.2025.101318 VERVE-101: A Promising CRISPR-Based Gene Editing Therapy That Reduces LDL-C and PCSK9 Levels in HeFH Patients https://academic.oup.com/ehjcvp/article/10/2/89/7492807 You may also like: Hear John Mandrola, MD, give a summary and his perspective on the top cardiology news each week, on This Week in Cardiology https://www.medscape.com/twic Questions or feedback, please contact news@medscape.net

DOWNLOAD "THE POWER OF TOO MUCH," our FREE modern-day grimoire that helps you reclaim your intensity, your magic, and your voice: ⁠https://babephilosophy.com⁠

What if one side of your body suddenly stopped moving — and your doctor said, “It's a migraine”?Hemiplegic migraines are rare, disorienting, and often confused with strokes. They challenge everything you think you know about how your brain, body, and energy connect.In this episode of Migraine Heroes Podcast, hosted by Diane Ducarme, we explore the science and the story behind this rare form of migraine — one that blurs the line between neurology and mystery. Together, we look at how the body can temporarily lose its flow, and how to gently help it find its rhythm again.In this episode, you'll learn:

This week on Fat Science, Dr. Emily Cooper, Mark Wright, and Andrea Taylor dive into the latest U.S. blood pressure guidelines—and reveal why nearly half of all Americans face risks that can no longer be ignored. Early intervention and smart lifestyle changes are at the heart of these new recommendations.Why is high blood pressure such a hidden danger? What do the new “elevated” and “stage one” categories mean for real people? How do doctors decide when it's time for medication versus lifestyle changes? And how does blood pressure connect to kidneys, strokes, and even dementia? Dr. Cooper unpacks the science, gives practical advice, and shares why home monitoring is now a crucial part of medical care.In this conversation-dense episode, the team breaks old myths and empowers listeners to take charge—so that “keeping an eye” on blood pressure becomes active prevention, not passive worry.Key Takeaways:New guidelines lower the bar for concern—120 over 80 is now “caution,” and 130 over 80 is “hypertension.” Early action matters.Untreated high blood pressure can lead to irreversible organ damage, strokes, kidney disease, and cognitive decline.Doctors now have a better toolkit: updated cutoffs, risk “calculators” that include zip code, and clearer protocols for who needs medication right away.Lifestyle changes (fruit, vegetables, less sodium, more movement, quality sleep, stress management, and alcohol moderation) are the first line for many—especially in the “elevated” category.Metabolic syndrome often includes high blood pressure; medicines like GLP-1s and metformin may help regulate pressure as well as metabolism.Accurate home blood pressure monitoring is strongly recommended, with validated cuff meters (not wrist models).Dr. Cooper shares actionable tips:Eat five servings of fruits and vegetables daily for potassium—bananas, spinach, potatoes, kiwis all help.Get a “validated” cuff monitor and check morning/evening, resting, following best practices.Ask your doctor about the new guidelines and risk calculators (found at the American Heart Association website).Notable Quote:“Home readings are very valuable. I really encourage people to look at the Validate BP site, find a good meter, and keep a log. Catching high blood pressure early and treating it aggressively can have profound impacts on your future health.”— Dr. Emily CooperResources from the episode:Fat Science is your source for understanding why blood pressure—and metabolic health—matter more than ever. No diets, no agendas, just science that makes you feel better.This show is informational only, not medical advice.Check out our website to submit a question to the listener mailbag.Have questions for Dr. Cooper, a show idea, feedback, or just want to connect?Email questions@fatsciencepodcast.com or dr.c@fatsciencepodcast.com.Connect with:Dr. Emily Cooper on LinkedInMark Wright on LinkedInAndrea Taylor on Instagram

If there's anyone who proves that planning is a form of art, it's Susan Wetzel. Whether she's mapping out her one-, five-, or ten-year goals, or guiding clients through the legal maze of mergers and acquisitions, Susan doesn't wing it, she designs it. Every decision, every move, every cup of tea.Her brew of choice? Ginger turmeric tea for its bold, balanced, and quietly powerful impact, much like her approach to leadership and life.In this episode of Counsel Brew, Susan walks us through how she builds a career and a life by design. From her habit of printing every draft before she hits send (even emails!) to her meticulous approach to long-term planning, Susan shows us that being intentional doesn't mean being rigid…It means making room for what matters most.She also shares her deep commitment to the American Heart Association, where she channels her leadership beyond the boardroom, advocating for stronger, healthier communities with the same energy and focus she brings to her work.And because life's not all paper and plans, Susan lets us peek behind the scenes where Halloween and costumes reign supreme. From full-on costumes to an enthusiasm that could give the neighborhood kids a run for their candy, she reminds us that joy isn't just something to schedule in; it's something to celebrate.This episode is for the planners, the thinkers, and anyone who finds peace in a well-organized stack of paper, a perfectly steeped cup of tea, and a great costume idea waiting in the wings.

The Rich Zeolli Show- Full Show (10/22/2025): 3:05pm- Democrats and media members are apoplectic over the Trump administration's decision to construct a grand ballroom at the White House—expanding the residence's East Wing. President Trump has insisted construction will be privately funded, at no expense to the taxpayer. Despite left-wing outrage, Teddy Roosevelt, William Howard Taft, Woodrow Wilson, Calvin Coolidge, Herbert Hoover, Franklin Delano Roosevelt, Harry Truman, John F. Kennedy, Richard Nixon, Gerald Ford, Bill Clinton, and Barack Obama all oversaw major construction projects while serving as president. Speaker Mike Johnson noted during a press conference earlier today: This is proof Democrats will attack President Trump for anything and everything he does. 3:30pm- Congressman Byron Donalds (R-FL) is in New Jersey campaigning alongside Jack Ciattarelli. While on the show yesterday, Rep. Donalds emphasized that Mikie Sherrill is no moderate: “I served with her. I know how she votes. She is a RADICAL.” 3:45pm- Health and Human Services Secretary Robert F. Kennedy Jr. is expected to issue new dietary guidance encouraging Americans to increase saturated fat consumption. 4:00pm- Health and Human Services Secretary Robert F. Kennedy Jr. is expected to issue new dietary guidance encouraging Americans to increase saturated fat consumption. Will the American Heart Association update its own guidance? They currently state: “Saturated fats are found in butter, cheese, red meat, other animal-based foods and tropical oils. Decades [of] science has proven that saturated fats can raise your ‘bad' cholesterol and put you at higher risk for heart disease.” 4:10pm- During a segment on Piers Morgan Uncensored, progressive commentator/activist Harry Sisson said: “I dare you to name one high-ranking Democrat who compared Trump to Hitler.” Rich plays clips of then-President Joe Biden and Vice President Kamala Harris both doing it prior to the 2024 election! 4:20pm- Democrats and media members are apoplectic over the Trump administration's decision to construct a grand ballroom at the White House—expanding the residence's East Wing. President Trump has insisted construction will be privately funded, at no expense to the taxpayer. Despite left-wing outrage, Teddy Roosevelt, William Howard Taft, Woodrow Wilson, Calvin Coolidge, Herbert Hoover, Franklin Delano Roosevelt, Harry Truman, John F. Kennedy, Richard Nixon, Gerald Ford, Bill Clinton, and Barack Obama all oversaw major construction projects while serving as president. Speaker Mike Johnson noted during a press conference earlier today: This is proof Democrats will attack President Trump for anything and everything he does. 4:30pm- Cracker Barrel Logo Change: Cracker Barrel CEO Julie Felss Masino explained that the restaurant chain's short-lived logo change wasn't ideological—instead, it was intended to make highway signs more visible. 5:00pm- Sheriff Shaun Golden—Monmouth County Sheriff—joins The Rich Zeoli Show to preview New Jersey's November 4th election. Earlier today, Sheriff Golden attended Jack Ciattarelli's diner tour with Congressman Byron Donalds (R-FL). 5:20pm- On Wednesday afternoon, President Donald Trump met with Secretary General of NATO Mark Rutte in the Oval Office. While taking questions from the press, President Trump discussed his administration's targeted strikes on drug-carrying boats from Venezuela, a recently canceled summit with Russian President Vladimir Putin, and his White House renovations! 5:50pm- Is Rich still angry that he didn't get a “Baier hug” while at Fox News? Newman Price creates two new songs about the incident—do you prefer the country or death metal version? 6:05pm- Terry Schilling—President of the American Principles Project—joins The Rich Zeoli Show to discuss the governor's race in New Jersey. To learn more about the American Principles Project visit: https://americanprinciplesproject.org/about/. 6:30pm- While speaki ...

The Rich Zeoli Show- Hour 2: 4:00pm- Health and Human Services Secretary Robert F. Kennedy Jr. is expected to issue new dietary guidance encouraging Americans to increase saturated fat consumption. Will the American Heart Association update its own guidance? They currently state: “Saturated fats are found in butter, cheese, red meat, other animal-based foods and tropical oils. Decades [of] science has proven that saturated fats can raise your ‘bad' cholesterol and put you at higher risk for heart disease.” 4:10pm- During a segment on Piers Morgan Uncensored, progressive commentator/activist Harry Sisson said: “I dare you to name one high-ranking Democrat who compared Trump to Hitler.” Rich plays clips of then-President Joe Biden and Vice President Kamala Harris both doing it prior to the 2024 election! 4:20pm- Democrats and media members are apoplectic over the Trump administration's decision to construct a grand ballroom at the White House—expanding the residence's East Wing. President Trump has insisted construction will be privately funded, at no expense to the taxpayer. Despite left-wing outrage, Teddy Roosevelt, William Howard Taft, Woodrow Wilson, Calvin Coolidge, Herbert Hoover, Franklin Delano Roosevelt, Harry Truman, John F. Kennedy, Richard Nixon, Gerald Ford, Bill Clinton, and Barack Obama all oversaw major construction projects while serving as president. Speaker Mike Johnson noted during a press conference earlier today: This is proof Democrats will attack President Trump for anything and everything he does. 4:30pm- Cracker Barrel Logo Change: Cracker Barrel CEO Julie Felss Masino explained that the restaurant chain's short-lived logo change wasn't ideological—instead, it was intended to make highway signs more visible.

rWotD Episode 3090: Lipid-lowering agent Welcome to random Wiki of the Day, your journey through Wikipedia's vast and varied content, one random article at a time.The random article for Sunday, 19 October 2025, is Lipid-lowering agent.Lipid-lowering agents, also sometimes referred to as hypolipidemic agents, cholesterol-lowering drugs, or antihyperlipidemic agents are a diverse group of pharmaceuticals that are used to lower the level of lipids and lipoproteins, such as cholesterol, in the blood (hyperlipidemia). The American Heart Association recommends the descriptor 'lipid lowering agent' be used for this class of drugs rather than the term 'hypolipidemic'.This recording reflects the Wikipedia text as of 00:15 UTC on Sunday, 19 October 2025.For the full current version of the article, see Lipid-lowering agent on Wikipedia.This podcast uses content from Wikipedia under the Creative Commons Attribution-ShareAlike License.Visit our archives at wikioftheday.com and subscribe to stay updated on new episodes.Follow us on Mastodon at @wikioftheday@masto.ai.Also check out Curmudgeon's Corner, a current events podcast.Until next time, I'm generative Kajal.

Heart disease is the most common serious chronic condition among adults. In fact per the latest report staggering 1 in 3 US adults received care for a cardiovascular risk factor or condition in 2020. The same report projects that annual inflation-adjusted health care costs attributable to cardiovascular conditions will nearly quadruple from $393 billion in 2020 to $1,490 billion by 2050.Truly astounding numbers. Heart disease is an umbrella term that encompasses coronary artery disease, heart failure, valvular disease, arrhythmias, congenital heart disease, cardiomyopathies, and other structural or functional heart disorders.But, despite this complexity, there is clear guidance from the American Heart Association about what to do to improve and maintain heart health, they call them them Life's Essential 8: 1. Consume a healthy diet emphasizing vegetables, fruits, nuts, whole grains, lean proteins (including fish), and minimizing trans fats, red and processed meats, refined carbohydrates, and sweetened beverages.2. Maintain a healthy body weight through caloric restriction and counseling for those with overweight or obesity.3. Engage in regular physical activity, specifically at least 150 minutes per week of moderate-intensity or 75 minutes per week of vigorous-intensity exercise.4. Avoid tobacco products and exposure to secondhand smoke.5. Limit alcohol intake to moderate levels, if consumed at all.6. Manage blood pressure through lifestyle changes and, if needed, medication.7. Control blood cholesterol with diet, physical activity, and medication when indicated.8. Prevent and manage diabetes with lifestyle modifications and appropriate pharmacologic therapy when necessary.We know that behavioral counseling for these lifestyle changes can be effective. But, to date, occupational therapy has been underutilized in this critical public health initiative. In today's course, we'll talk to one occupational therapist, Sabina Kahn, who is using her OT skill-set to help tackle this large scale problem, through new technologies. We'll discuss why OT has been under-utilized to date, what opportunities exist for OTs to play a larger role, and what new technologies might help us step into this critical role, with our unique expertise.Support the show

On this week's show, we bring you a community conversation about "The Last Decade of Life and How to Spend it Outside of the Hospital." This event on September 30, 2025 at the Filson Historical Society in Old Louisville was presented by the University of Louisville's Christina Lee Brown Envirome Institute in collaboration with the Filson. This Distinguished Lecture Series lecture offered a timely and important exploration of how we can live healthier, disease-free lives. Centered around the concept of healthspan — the portion of life spent in good health, as distinct from total lifespan — the session challenged us to think differently about what it means to pursue health, rather than merely reduce disease risk. Leaders from the Christina Lee Brown Envirome Institute reflect on their multiyear journey shaping a research agenda that reframes medicine around the foundations of well-being. Drawing from robust scientific evidence, the talk highlights key building blocks of health — including nature, nutrition, and community — and why these require renewed attention in medical research and health systems. The presentation also offers practical insights into what individuals can do now to promote their own healthspan. Local examples, especially in nature-based interventions and the possibilities of diet, help ground these ideas in real-world impact. The program begins with a brief overview of the history and groundbreaking accomplishments of the Envirome Institute by Dr. Ted Smith. Then we hear from Dr. Aruni Bhatnagar, the Smith & Lucille Gibson Professor of Medicine, Chief of the Division of Environmental Medicine, and Director of the Christina Lee Brown Envirome Institute at the University of Louisville. A Fellow of the American Heart Association, he is recognized as a pioneer in the field of environmental cardiology. His research explores how oxidative stress from internal and environmental sources contributes to cardiovascular disease. Dr. Bhatnagar leads major initiatives such as the Green Heart Louisville Project and has authored hundreds of scientific publications while mentoring a large research team. Learn more at https://louisville.edu/envirome On Truth to Power each week, we bring you community conversations like you won't hear anywhere else! Truth to Power airs every Friday at 9pm, Saturday at 11am, and Sunday at 4pm on Louisville's grassroots, community radio station, Forward Radio 106.5fm WFMP and live streams at https://www.forwardradio.org. If you like what you hear, share it with someone, donate to keep us on-air, and get involved as a volunteer!

In this powerful kickoff to a collaborative series with the AHA Women in Cardiology (WIC) Committee, CardioNerds (Dr. Apoorva Gangavelli, Dr. Gurleen Kaur, and Dr. Jenna Skowronski) explore the evolving landscape of women in advanced heart failure and transplant cardiology, featuring insights from two inspiring leaders in the field. Dr. Mariell Jessup, Chief Science and Medical Officer of the American Heart Association, reflects on her decades-long journey in heart failure cardiology, from navigating early career barriers to becoming a trailblazer in clinical leadership and research. Dr. Nosheen Reza, an advanced heart failure and transplant cardiologist at the University of Pennsylvania, shares how Dr. Jessup's pioneering work has inspired her own career and shaped her approach to mentorship, advocacy, and academic development. Together, they discuss the systemic challenges women continue to face, the importance of sponsorship, and the evolving culture within cardiology. Listeners will gain a multigenerational perspective on how far the field has come and what is still needed to ensure equity, excellence, and innovation in advanced heart failure care. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Heart Success Series PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! References DeFilippis EM, Moayedi Y, Reza N. Representation of Women Physicians in Heart Failure Clinical Practice. Card Fail Rev. 2021;7:e05. Published 2021 Mar 31. doi:10.15420/cfr.2020.31 

In this episode, we discuss: ●How sleep and diet directly influence each other. ●How specific dietary patterns and specific nutrients can improve sleep, and how processed foods may worsen it. ●Ways you can restore the body through REM support for memory and learning. ●How aging and menopause influence sleep ●How light exposure therapy works and how light at night (LAN) can disrupt sleep cycles ●How common disorders like sleep apnea disrupt sleep cycles and how they can be managed effectively. ●How consistent routines, stress reduction, and a healthy environment improve sleep quality. ●If naps are a good idea….and under which circumstances you can maximize their benefits? ●How adequate sleep quality & quantity supports weight regulation, metabolism, and overall heart health. Marie-Pierre St-Onge, Ph.D, CCSH, FAHA  Professor of Nutritional Medicine  Director, Center of Excellence for Sleep & Circadian Research  Division of General Medicine, Department of Medicine  College of Physicians and Surgeons Columbia University Irving Medical Center Address: 622 West- 168 th Street, PH9-103H New York, NY 10032 E-mail: ms2554@cumc.columbia.edu Dr. St-Onge is the founding Director of the Center of Excellence for Sleep Circadian Research at Columbia University Irving Medical Center. The overall focus of her research is the study of the impact of lifestyle, specifically sleep and diet, on cardio-metabolic risk factors. Dr. St-Onge has been NIH-funded since 2008, conducting innovative, cutting-edge clinical research combining her expertise on sleep, nutrition, and energy balance regulation to address questions related to the role of circadian rhythms, including sleep duration and timing as well as meal timing and eating patterns, on cardiometabolic risk. She has strong expertise in the conduct of controlled inpatient and outpatient studies of sleep and dietary manipulations. Dr. St-Onge was Center Director for the American Heart Association funded Go Red for Women Strategically Focused Research Center, aimed at determining the causality of the relation between sleep and cardiovascular disease and the specific role that sleep plays in the health of women throughout the life cycle. She is a pioneer in this field, having chaired the first scientific statements endorsed by the AHA on sleep and cardiometabolic health as well as meal timing and frequency and cardiovascular disease risk prevention. She is the recipient of an NHLBI Outstanding Investigator Award and a standing member of the Human Studies of Diabetes and Obesity Study Section at the NIH.

In August, organizations including the American Heart Association and AANP worked to update the guidelines for the prevention, detection, evaluation and management of high blood pressure in adults. This is the first update on these guidelines since 2017 and will change the way health care providers approach hypertension. To walk us through what has changed are NPs Leslie Davis and Margaret “Midge” Bowers, AANP Fellows who helped draft and publish these important updates. 

In 1968, the American Heart Association made an announcement that would influence people's diets for decades: they recommended that people avoid eating more than three eggs a week. Their reasoning was that the cholesterol packed into egg yolks could increase cardiovascular disease risk. So, what exactly is cholesterol? And is it actually bad for you? Hei Man Chan digs into this complex molecule. [Directed by Igor Ćorić, Artrake Studio, narrated by Addison Anderson, music by Cem Misirlioglu].After the talk, Shoshana interviews Dr. Eric Topol, a cardiologist and founder of the Scripps Research Translational Institute on AI, genomics, and the digital tools that are revolutionizing the way we prevent, detect, and treat illness—including heart disease. Hosted on Acast. See acast.com/privacy for more information.

In a wide-ranging conversation, I sat down with Renée Gaddis, founder of Renée Gaddis Interiors, to explore Florida's distinct design influences, the evolving role of designers in storm-prone regions, and the business of luxury interiors in uncertain times. Speaking from Naples, Florida, Gaddis compared her region's design sensibilities to other parts of the state, noting a blend of Midwestern, European, and Southern traditions. While many of her clients lean toward transitional or traditional styles, she observed that Miami remains more open to modern aesthetics. Designer Resources Pacific Sales Kitchen and Home. Where excellence meets expertise. Design Hardware - A stunning and vast collection of jewelry for the home! TimberTech - Real wood beauty without the upkeep LOME-AI.com, simple, inexpensive, text to video harnessing the power of AI to grow your firm, beautifully. The discussion turned to real estate trends fueled by the pandemic, which brought an influx of new homeowners to Florida. Gaddis shared how this surge, combined with a major hurricane, reshaped her approach to client selection and project scope. She emphasized her boutique model, strong referral base, and commitment to seamlessly integrating interiors with exteriors to embrace Florida's indoor-outdoor lifestyle. On the financial side, she addressed rising costs and tariffs that have altered project budgets, leading to value engineering and sourcing U.S.-made products. Gaddis also reflected on the importance of partnerships with trades and vendors, especially during supply chain volatility, while advocating for transparent communication to maintain trust. The conversation also touched on resilient building practices in storm-prone regions. Gaddis highlighted lessons learned from past hurricanes, from identifying flawed hurricane-rated windows to designing with better drainage, elevated platforms, and even safe rooms. Her insights underscored the need for long-term sustainability in luxury projects. Beyond design, Gaddis shared her family's advocacy journey with the American Heart Association, inspired by her daughter's early diagnosis and treatment. This personal commitment, alongside her professional expertise, reflects her philosophy that resilience—whether in design or life—is built through experience, adaptability, and care. And you are going to hear the whole story, right after this. Thank you, Renee. Amazing. Loved our chat and appreciate the time. Thank you for listening. If you liked this episode, share it with a friend or colleague who loves design and architecture like you do, subscribe to Convo By Design wherever you get your podcasts. And continue the conversation on Instagram @convo x design with an “x”. Keep those emails coming with guest suggestions, show ideas and locations where you'd like to see the show. Convo by design at outlook.com. Thank you to my partner sponsors, TimberTech, The AZEK Company, Pacific Sales, Best Buy, LOME-AI and Design Hardware. These companies support the shelter industry so give them an opportunity on your next project. Thanks again for listening. Until next time, be well, stay focused and rise about the chaos. -CXD

Nutrition scientist Dr. Christopher Gardner is at the forefront of the debate on ultra processed foods (UPFs). Some experts say you should avoid them entirely, while others (including the American Heart Association) argue that certain processed foods can fit into a healthy diet.   Dr. Gardner joins Chuck Carroll at the International Conference on Nutrition and Medicine (ICNM) to help cut through the confusion and conflicting advice.   In this episode of The Exam Room Podcast, you'll learn:   - What “ultra processed foods” really are - Why not all UPFs are equally harmful - The surprising reasons some healthier foods cost more - The top food additives and ingredients to avoid - How to read labels to make smarter choices   If you feel like you've raised your health IQ, please leave a 5-star rating and nice review on Apple Podcasts or Spotify.   Discover Dr. Neal Barnard's advice about which processed foods are healthy.   About Us The Physicians Committee is dedicated to saving lives through plant-based diets and ethical and effective scientific research. We combine the clout and expertise of more than 17,000 physicians with the dedicated actions of more than 175,000 members across the United States and around the world.